•a‘Ô§ŒäˆãŠwuÀ^“à‰ÈŠwi2j—̈æ
•‘®•a‰@^‘æ“ñ“à‰È

 

1D  —̈æ\¬‹³EˆõEÝEŠúŠÔ

‹³Žö

’†–{@ˆÀ¬

•½¬23”N1ŒŽ\

y‹³Žö

à_–ì@’‰‘¥

•½¬2”N6ŒŽ\•½¬3”N3ŒŽC•½¬9”N7ŒŽ\•½¬9”N8ŒŽC •½¬10”N4ŒŽ\•½¬11”N3ŒŽC•½¬12”N4ŒŽ\ •½¬16”N3ŒŽC•½¬16”N4ŒŽ\•½¬18”N6ŒŽ(—¯Šw)C•½¬18”N7ŒŽ\i•½¬25”N4ŒŽ\Œ»Ej

y‹³Žöi’nˆæ‚“xˆã—ÄiuÀj

{“¡@O”V

•½¬4”N6ŒŽ\•½¬5”N5ŒŽC•½¬7”N10ŒŽ\•½¬8”N3ŒŽC •½¬14”N4ŒŽ\•½¬14”N8ŒŽC•½¬14”N9ŒŽi—¯Šw)\•½¬16”N6ŒŽC•½¬16”N7ŒŽ\i•½¬25”N4ŒŽ|Œ»Ej

‹³

ª–{@•üK

•½¬16”N2ŒŽ\i•½¬22”N4ŒŽ|Œ»Ej

• ‹³

‘å’J@¹O

•½¬8”N4ŒŽ|•½¬9”N3ŒŽC•½¬14”N4ŒŽ|•½¬16”N9ŒŽC•½¬16”N10ŒŽi—¯Šwj|•½¬18”N9ŒŽC•½¬18”N10ŒŽi•½¬15”N9ŒŽ|Œ»Ej

‹³

—Ñ@_Žk

•½¬8”N4ŒŽ|•½¬9”N3ŒŽC•½¬11”N5ŒŽ|•½¬12”N4ŒŽC•½¬14”N5ŒŽ|•½¬15”N3ŒŽC•½¬26”N4ŒŽ|Œ»E

• ‹³

ˆäì@³“¹

•½¬12”N5ŒŽ\•½¬13”N5C•½¬15”N4ŒŽ\•½¬17”N3ŒŽC•½¬18”N5ŒŽ\•½¬25”N10ŒŽC•½¬25”N11ŒŽi—¯Šwj\i•½¬22”N4ŒŽ|Œ»Ej

• ‹³

¼‰i@»Žq

•½¬14”N5ŒŽ|•½¬15”N4ŒŽC•½¬17”N4ŒŽ|i•½¬23”N4ŒŽ|Œ»Ej

 

 

 

2D  Œ¤‹†ŠT—v

œ  Œ¤‹†ŠT—v

“–—̈æ‚Å‚ÍŽå‚Æ‚µ‚ÄA1jÁ‰»ŠíƒOƒ‹[ƒvA2j_ŒoƒOƒ‹[ƒv‚É‚æ‚錤‹†‚ðŽÀŽ{‚µ‚Ä‚¢‚éB

 

œ  –{Šw‚Ì—”O‚Æ‚ÌŠÖŒW

–{ŠwˆãŠw•”‚Ì—”O‚ÍA‘–¯«A‘Û«Aæi«A—Ï—«‚ÉŠî‚¢‚½ˆã—Â̋‰»‚Æ«—ˆ«‚ðŒ©’Ê‚µ‚½Œ¤‹†‚ÌŽÀs‚Ælވ笂ł ‚éB’S“–‚·‚鎾Š³‘Îۗ̈æ‚ÍA‚Ü‚³‚É‘–¯•a‚Æ‚¢‚¦‚鎾Š³‚Å‚ ‚éÁ‰»ŠíŠàA”]‘²’†A”F’mÇA_Œo“ï•a‚È‚Ç‚ðŽå‚Æ‚µ‚ÄŽæ‚舵‚Á‚Ä‚¨‚èA‘–¯‚ÌŒ’N‚Ì•ÛŒì‚Æ‘i‚ׂ̈Éf—ÃAŒ¤‹†‚ðs‚Á‚Ä‚¢‚éB‚Ü‚½‘“à‚Ì‘åŠw‚¨‚æ‚Ñ‘ŠO‚Ì‘åŠwŒ¤‹†Š(MIT, Mayo Clinic)‚Æ‚Ì‹¤“¯Œ¤‹†‚¨‚æ‚Ñlތ𗬂às‚Á‚Ä‚¨‚èAŒ¤‹†‚Å‚Í¢ŠE‚Éæ‹ì‚¯V‚µ‚¢Ž–ŽÀ‚𖾂炩‚É‚µ‚Ä‚¢‚éB
‚±‚ê‚ç‚ÌŒ¤‹†‚ð’Ê‚µ‚Ä‘Û“I‚É’Ê—p‚·‚éæ’[ˆã—Â̊J”­‚ð–ÚŽw‚µA‚³‚ç‚É‚Í‘–¯‘S‘Ì‚ÌŒ’N‘i‚ÉvŒ£‚·‚邱‚Æ‚ð–Ú•W‚Æ‚µ‚Ä‚¢‚éB

 

Á‰»Ší“à‰ÈƒOƒ‹[ƒv

 

œ  Œ¤‹†ŠT—v

Á‰»Ší“à‰ÈƒOƒ‹[ƒv‚ÍA’†–{‹³Žöi‰È’·jA{“¡y‹³Žöi•›‰È’·jA•½¼y‹³ŽöAª–{•‹³A‘å’J•‹³A¼“c•‹³A“à“¡•a‰@•‹³‚ðƒXƒ^ƒbƒt‚Æ‚µ‚ÄAÁ‰»Ší“àŽ‹‹¾iãE‰º•”Á‰»ŠÇ“àŽ‹‹¾A’_äX“àŽ‹‹¾A’´‰¹”g“àŽ‹‹¾“™jA• •”’´‰¹”g‚ð—p‚¢‚½f’fEŽ¡—ÃŽè‹Z‚ðŽ{s‚µAŠeŽíÁ‰»ŠíŽ¾Š³‚ɑ΂µf’fEŽ¡—Âðs‚Á‚Ä‚¢‚éBŽå‚Èf—À–Ú‚Æ‚µ‚ÄA‚PjH“¹ŠàAˆÝŠàA‘å’°ŠàA‘å’°‘BŽî‚ɑ΂·‚é“àŽ‹‹¾“I”S–Œ‰º‘wØŠJ”—£piESDjA‚QjŠÌŠà‚ɑ΂·‚郉ƒWƒI”gÄŽÜpiRFAjA5-FU“®’/IFN•¹—p—Ö@A–Ɖu•â•—Ö@A‚RjÁ‰»ŠÇA’_äXŽ¾Š³‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾‰ºúŽh‹zˆøpiEUS-FNAj‚ð—p‚¢‚½f’fEŽ¡—ÃA‚Sjis’_“¹Šà‚âäXŠà‚ɑ΂·‚é“àŽ‹‹¾“IŒ¸‰©Ž¡—ÃA‚TjHelicobacter pyloriiH. pylorijŠ´õÇ‚Ìf’fEŽ¡—ÃA‚Uj¬’°Ž¾Š³‚ɑ΂·‚éƒJƒvƒZƒ‹“àŽ‹‹¾ŒŸ¸Aƒoƒ‹[ƒ““àŽ‹‹¾ŒŸ¸A‚VjBŒ^ŠÌ‰ŠACŒ^ŠÌ‰Š‚ɑ΂·‚éRƒEƒCƒ‹ƒXŽ¡—ÂȂǂðs‚Á‚Ä‚¢‚éB
•½¬16”N10ŒŽ‚©‚ç‚͈݊à‚ɑ΂·‚éƒI[ƒ_[ƒƒCƒhˆã—Â̈êŠÂ‚Æ‚µ‚ÄAê–åŠO—ˆ‚Æ‚µ‚Ä‚ÌuƒsƒƒŠŠO—ˆv‚ðŠJÝ‚µAÅ‹ß‚Å‚ÍŽOŽŸœ‹ÛŽ¡—ÂðÏ‹É“I‚És‚Á‚Ä‚¢‚éB‚Ü‚½AŽèp•s”\ŠÌ×–EŠà‚ɑ΂·‚éŠÌ“®–¬Çð—Ö@iTAEj‚ÆŽ÷ó×–E–ƉuŽ¡—ÂÌæiˆã—Âð–ÚŽw‚µ‚½—Õ°ŽŽŒ±‚ðŠJŽn‚µAÁ‰»ŠíŠà‚ɑ΂·‚éV‚½‚ÈŽ¡—Ö@‚ÌŠJ”­‚É’§í‚µ‚Ä‚¢‚éB
Žå‚ÈŒ¤‹†ƒe[ƒ}‚ÍA‚PjH. pyloriŠ´õ‚É‚¨‚¯‚éÁ‰»ŠíŽ¾Š³‚Ì—Õ°•a‘Ô‰ðÍ‚È‚ç‚Ñ‚ÉH.pylori‹Û‘Ì•aŒ´ˆöŽq‚ÆhŽå–Ɖu”½‰ž‚̉ðÍA‚Qj—«ƒzƒ‹ƒ‚ƒ“‚̈ݔ­Šà—}§ì—p‚̉ðÍA‚Rj—Î’ƒƒJƒeƒLƒ“A–hŒäˆöŽq»Ü‚Ȃǂ̈ݔ­Šà—}§ì—p‚̉ðÍA‚SjNSAIDs‹Nˆö«Á‰»ŠÇ”S–ŒáŠQ‚Ì•a‘Ô‰ðÍA‚Tjƒ}ƒCƒNƒƒLƒƒƒrƒeƒBƒAƒŒƒC‰t‘̶ŒŸ‹Zp‚ð—p‚¢‚½ŠÌ‚ª‚ñÄ”­’´‘Šúf’f–@‚ÌŠJ”­A‚UjŠÌ‰Š‚É‚¨‚¯‚émiRNA‚̉ðÍA‚VjCŒ^ŠÌ‰ŠŠ³ŽÒ‚É‚¨‚¯‚éHLA-class‡U—̈æ‚ÌSNP‰ðÍA‚WjŠÌ×–EŠà‚ɑ΂·‚鎡—Ê´Žó«ˆöŽq‚Ì’TõA‚X) ƒ‰ƒWƒI”gÄŽÜ‚¨‚æ‚ÑTAEŒãƒAƒWƒ…ƒoƒ“ƒh“Š—^‚É‚æ‚éŠÌŠà–Ɖu•â•—Ö@‚ÉŠÖ‚·‚é—Õ°Œ¤‹†A‚P‚O) ŠÌƒGƒlƒ‹ƒM[‘ãŽÓ‚ÉŠÖ—^‚·‚éV‹K“]ŽÊ—}§ˆöŽq‚Ì‹@”\‰ðÍA‚P‚P) Ž©ŒÈ–Ɖu«ŠÌ‰Š‚ÉŠÖ—^‚·‚é“]ŽÊ’²ßˆöŽq‚̉ðÍA‚P‚QjBŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚Ì•a‘Ô‰ðÍ‚È‚Ç‚Å‚ ‚éB

 

œ  ƒL[ƒ[ƒh

ŠÌ‰Š, ŠÌŠà, Helicobacter pyloriŠ´õÇ

 

œ  ‹ÆÑ”N‚Ìi’»ó‹µ

‚±‚±””N‚ÌŠî‘bŒ¤‹†E—Õ°Œ¤‹†‚̬‰Ê‚ð•Ä‘ŠÌ‘ŸŠw‰ï‹ciAASLDjA‰¢BÁ‰»Ší•aTŠÔiUEGWjA“ú–{Á‰»Ší•aŠw‰ïA“ú–{ŠÌ‘ŸŠw‰ï‚È‚Ç‚Ì‘“àŠO‚ÌŠw‰ï‘‰ï‚È‚Ç‚Å”­•\‚µ‚½B‚Ü‚½AisŠÌŠà‚É‚¨‚¯‚鎡—ÑI‘ð‚ɂ‚¢‚ÄŒ´’˜˜_•¶‚Æ‚µ‚Ä”­•\‚µAESD‚ðŽ{s‚µ“¾‚½‹H‚È•\ÝŒ^H“¹—ÞŠî’ê×–EŠà‚Ì1—á‚ɂ‚¢‚ÄÇ—á•ñ‚Æ‚µ‚Ę_•¶”­•\‚µ‚½B

 

œ  “ÁF“™

“–‰È‚Å‚ÍH. pylori—Õ°•ª—£Š”‚̈â“`Žq‰ðÍ‚¨‚æ‚уKƒXƒgƒŠƒ“ƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚ð—p‚¢‚½Š´õŽÀŒ±‚ð’Ê‚µ‚ÄAH. pyloriŠ´õ‚É‚¨‚¯‚éˆÝ”­Šà‹@\‚̉ðÍ‚ðs‚¤‚Æ‚Æ‚à‚ÉA—Õ°•a‘Ô‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚ĉðÍ‚ðs‚Á‚Ä‚«‚½B¡ŒãAH. pyloriŠ´õÇ‚¨‚æ‚ъ̉ŠAŠÌŠà‚Ì•a‘Ô‰ðÍ‚ðs‚¢AÁ‰»ŠíŠà‚É‚¨‚¯‚鉊ǔ­Šà‚Ì•ªŽq‹@\‚̉𖾂Ƃ»‚ÌŽ•ž‚ð–Ú•W‚ÉŒ¤‹†‚ði‚ß‚é—\’è‚Å‚ ‚éB

 

_Œo“à‰ÈƒOƒ‹[ƒv

 

œ  Œ¤‹†ŠT—v

_Œo“à‰ÈƒOƒ‹[ƒv‚ÍAà_–ìy‹³Žöi‰È’·jAŽR‘ºuŽti•›‰È’·jAˆäì•‹³A¼‰i•‹³‚ðƒXƒ^ƒbƒt‚Æ‚µ‚Ĉȉº‚ÌŒ¤‹†ƒe[ƒ}‚ÉŽæ‚è‘g‚ñ‚Å‚¢‚éB‚Pjƒ~ƒgƒRƒ“ƒhƒŠƒA•a‚̈ê‚‚ÌMELASŠ³ŽÒ‚âƒp[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚É‚¨‚¯‚éƒGƒlƒ‹ƒM[‘ãŽÓEŽ_‰»ƒXƒgƒŒƒX‚Ì”]‹@”\ƒCƒ[ƒWƒ“ƒOiMRIAPETji‚ƒGƒlƒ‹ƒM[Œ¤‚¨‚æ‚Ñ•úŽË«ˆãŠwŒ¤‹†Š‚Æ‚Ì‹¤“¯Œ¤‹†A•¶‰ÈÈŒ¤‹†”ÇjA‚QjMELAS”]‘²’†”­ìŽž‚ÌV–ò‚Å‚ ‚éL-ƒAƒ‹ƒMƒjƒ“‚Ì—Õ°Œø‰Ê‚â–ò—ì—p‚ÌŒŸ“¢i‹v—¯•Ä‘嬎™‰È‚Æ‚Ì‹¤“¯Œ¤‹†AŒú˜JȔnj¤‹†jA‚RjƒvƒƒeƒI[ƒ€‰ðÍ‚ð—p‚¢‚½‹´–{”]Ç‚ÌŽ©ŒÈR‘Ì‚Ì“¯’è‚Æ•a‘Ԃ̉ðÍiŒú˜JÈ‚¨‚æ‚Ñ•¶‰ÈÈŒ¤‹†”ÇjA‚SjƒAƒ‹ƒcƒnƒCƒ}[•a‚Ì•aˆö‚ÉŠÖ‚í‚éƒ^ƒE’`”’‚̃Šƒ“Ž_‰»¥d‡‹@\‚ÌŒŸ“¢‚ÆŽ¡—Öò‚ÌŠJ”­iMayo Clinic Jacksonville‚Æ‚Ì‹¤“¯Œ¤‹†A•¶‰ÈÈŒ¤‹†”ÇjA‚¨‚æ‚ÑŽ¡—Öò‚ÌŒø‰Ê‚Ì—Õ°“IŒŸ“¢A‚Tj”F’mÇ‚É‚¨‚¯‚éƒrƒ^ƒ~ƒ“Œ‡–R‚ÌŒ¤‹†A‚Uj‘å”]”玿Šî’êŠj•Ï«Ç‚ɑ΂·‚éCDP-Choline‚ÌŽ¡—ÃŒø‰Ê‚Ì”»’èi‚ƒGƒlƒ‹ƒM[Œ¤‚Æ‚Ì‹¤“¯Œ¤‹†jA‚Vj_Œo‹ØŽ¾Š³‚Ì‹ØMRIŠŒ©‚ÌŒŸ“¢(•úŽËü‰È‚Æ‚Ì‹¤“¯Œ¤‹†)A‚Wjד®–¬d‰»‚Ì•]‰¿Žw•W‚ÉŠÖ‚·‚錤‹†iŒú˜JÈŒ¤‹†”ÇjA‚Xjˆã—ÃIT‚ð—p‚¢‚½_ŒoŽ¾Š³‚Ì’nˆæ˜AŒg‚ÉŠÖ‚·‚錤‹†A‚P‚OjBrain Machine Interface(BMI)Œ¤‹†i“d‹C’ÊM‘åŠw‚Æ‚Ì‹¤“¯Œ¤‹†j‚È‚Ç‘½”s‚Á‚Ä‚¢‚Ü‚·B

 

œ  ƒL[ƒ[ƒh

ƒ~ƒgƒRƒ“ƒhƒŠƒA•a, ‹´–{”]Ç, ƒAƒ‹ƒcƒnƒCƒ}[•a, ƒp[ƒLƒ“ƒ\ƒ“•a, ”]ŒŒŠÇáŠQ

 

œ  ‹ÆÑ”N‚Ìi’»ó‹µ

ƒ~ƒgƒRƒ“ƒhƒŠƒA•a‚¨‚æ‚уp[ƒLƒ“ƒ\ƒ“•aA‚¨‚æ‚ÑALS‚É‚¨‚¯‚éPET‚ð—p‚¢‚½Ž_‰»ƒXƒgƒŒƒX‚Ì”]‹@”\ƒCƒ[ƒWƒ“ƒO‚ɉ‚߂ĬŒ÷‚µ‚½BƒvƒƒeƒI[ƒ€‰ðÍ‚ð—p‚¢‚Ä“¯’肵‚½‹´–{”]ÇŠ³ŽÒ‚Ìf’fƒ}[ƒJ[iRNAER‘Ìj‚ÍA‘“àŠO‚©‚ç”NŠÔ300ŒˆÈã‚̉ð͈˗Š‚ª‚ ‚èA–{Ž¾Š³‚Ìf’f‚É•K{‚Æ‚È‚Á‚Ä‚«‚½BƒXƒ^ƒ`ƒ“A‚o‚o‚`‚qƒÁƒAƒSƒjƒXƒgAROCK‘jŠQ–ò‚ðŽn‚ß‚Æ‚µ‚½ŠeŽí–òÜ‚É‚æ‚éTau’`”’ƒŠƒ“Ž_‰»—}§Œø‰Ê‚ª”|—{×–E‚Å–¾‚ç‚©‚Æ‚È‚Á‚½Bƒrƒ^ƒ~ƒ“‚a12A—tŽ_Œ‡–RÇ‚ª‚ƒzƒ‚ƒVƒXƒeƒBƒ“ŒŒÇ‚ð‚Ђ±‚¨‚±‚µA”F’m‹@”\‚ðˆ«‰»‚³‚¹‚邱‚Æ‚ðŽ¦‚µ‚½B‚³‚ç‚Ƀzƒ‚ƒVƒXƒeƒCƒ“‚É‚æ‚èƒ^ƒE’`”’‚Ìd‡‚ð‘£i‚·‚é‹@˜‚ð‰ð–¾‚µ‚½B‚Ü‚½–«”]’ázŠÂƒ}ƒEƒXƒ‚ƒfƒ‹‚ð—p‚¢Aƒ^ƒE‚̃Šƒ“Ž_‰»‘£i‚ðØ–¾‚Å‚«‚½B‹¤’ʂ̃NƒŠƒeƒBƒJƒ‹ƒpƒX‚È‚Ç‚ð—p‚¢‚½”]‘²’†‚Ì’nˆæ˜AŒg‚ª„i‚³‚êA‘S‘‚̃‚ƒfƒ‹ƒP[ƒX‚Æ‚µ‚Ä’–Ú‚³‚ê‚Ä‚¢‚éB‹Ø‹­’¼«ƒWƒXƒgƒƒtƒB[Š³ŽÒ‚Ì㎈MRIŠŒ©‚ÌŒŸ“¢‚É‚æ‚èáŠQ‹Ø‚ð‰‚ß‚Ä“¯’è‚Å‚«‚½B

 

œ  “ÁF“™

”]‘²’†AƒAƒ‹ƒcƒnƒCƒ}[•a‚âƒp[ƒLƒ“ƒ\ƒ“•a‚È‚Ç‚Ì‚È‚Ç‚Ì_Œocommon disease‚©‚çƒ~ƒgƒRƒ“ƒhƒŠƒA•aA‘å”]”玿Šî’êŠj•Ï«Ç‚ð‚Í‚¶‚ß‚Æ‚·‚é_Œo“ï•a‚Ì•a‘Ô‚ÆŽ¡—ÂɊւµ‚ÄAˆâ“`ŽqAƒvƒƒeƒIƒ~ƒNƒXA”|—{×–E‚ð—p‚¢‚½Šî‘b“IŒ¤‹†‚©‚çAPET‚âMRI‚ð—p‚¢‚½Š³ŽÒ‚Ì•a‘Ô‰ðÍ‚Ü‚Å•L‚¢Œ¤‹†‚ðs‚Á‚Ä‚¢‚éB‚Ü‚½A—Õ°’nˆæ˜AŒg‚Ì\’z‚Ȃǂ̈ã—ÃVƒXƒeƒ€‚ÉŒW‚錤‹†‚às‚Á‚Ä‚¢‚éB

 

 

 

3D  Œ¤‹†ŽÀÑ

‹æ@@•ª

•Ò@@”

ƒCƒ“ƒpƒNƒgƒtƒ@ƒNƒ^[ (‚¤‚¿Œ´’˜‚Ì‚Ý)

2009`2014”N•ª

2014”N•ª

2009`2014”N•ª

2014”N•ª

˜a•¶Œ´’˜˜_•¶

30

4

\\\\\

\\\\\

‰p•¶˜_•¶

̧°½Äµ°»°

21

3

59.406 ( 59.406)

2.773 ( 2.773)

ºÚ½ÎßÝÃިݸ޵°»°

16

2

36.546 ( 36.546)

0.000 ( 0.000)

‚»‚Ì‘¼

43

6

160.840 ( 159.116)

13.100 ( 11.376)

‡Œv

66

9

222.938 ( 221.214)

15.873 ( 14.149)

 

 

 

iAj  ’˜‘E˜_•¶“™

(1)  ‰p•¶F˜_•¶“™

aDŒ´’˜˜_•¶iR¸—Lj

1429000

+H.Nakagawa, +E.Mizukoshi, +N.Iida, +T.Terashima, +M.Kitahara, +Y.Marukawa, +K.Kitamura, Y.Nakamoto, +K.Hiroishi, +M.Imawari, +S.Kaneko: In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation. Cancer Immunol Immunother, 63i4j, 347-356, 2014.04, #3.943

 

1429001

*Takahisa Kawano, +Kohei Hasegawa, +Hiroko Watase, *H,Morita, O.Yamamura: Infectious Disease Frequency Among Evacuees at Shelters After the Great Eastern Japan Earthquake and Tsunami:A Retrospective Study. Disaster Medicine and Public Health Preparedness, 2014.04, #1.142

 

1429002

+T.Muramatsu, M.Ikawa, *M.Yoneda, *K.Sugimoto, A.Matsunaga, O.Yamamura, T. Hamano, *H.Okazawa, Y.Nakamoto: Pathophysiological decrease in the regional cerebral blood flow in Hashimotofs encephalopathy: a multiple-case SPECT study. Eur Neurology, 72i1-2j, 13-19, 2014.07, #1.362

 

1429003

+M.Kitahara, +E.Mizukoshi, Y.Nakamoto, +N.Mukaida, +K.Matsushima, +S.Kaneko: Efficient generation of highly immunocompetent dendritic cells from peripheral blood of patients with hepatitis C virus-related hepatocellular carcinoma. Int Immunopharmacol, 21i2j, 346-353, 2014.08, #2.711

 

1429004

+T.Yamashita, +A.Kitao, +O.Matsui, +T.Hayashi, +K.Nio, +M.Kondo, +N.Ohno, +T.Miyati, +H.Okada, +T.Yamashita, +E.Mizukoshi, +M.Honda, +Y.Nakanuma, +H.Takamura, +T.Ohta, Y.Nakamoto, +M.Yamamoto, +T.Takayama, +S.Arii, +X.Wang, +S.Kaneko: Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology, 60i5j, 1674-1685, 2014.11, #11.190

 

1429005

T.Nemoto, *H.Matsuda, T.Nosaka, Y.Saito, Y.Ozaki, R.Hayama, T.Naito, K.Takahashi, K.Ofuji, M.Ohtani, *K.Hiramatsu, H.Suto, Y.Nakamoto: Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series. Mol Clin Oncol, 2i6j, 1028-1034, 2014.11

 

1429006

+Y.Miyake, +K.Yamamoto, +H.Matsushita, +M.Abe, +A.Takahashi, +T.Umemura, +A.Tanaka, +M.Nakamuta, Y.Nakamoto, +Y.Ueno, +T.Saibara, +H.Takikawa, +K.Yoshizawa, +H.Ohira, +M.Zeniya, +M.Onji, +H.Tsubouchi: Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis. Hepatol Res, 44i13j, 1299-1307, 2014.12, #2.218

 

1429007

K.Ofuji, +Y.Tada, +T.Yoshikawa, +M.Shimomura, +M.Yoshimura, +K.Saito, Y.Nakamoto, +T.Nakatsura: A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer. Int J Oncol, 46i2j, 497-504, 2015.02, #2.773

 

1429008

Y.Ozaki, H.Suto, T.Nosaka, Y.Saito, T.Naito, K.Takahashi, K.Ofuji, *H.Matsuda, M.Ohtani, *K.Hiramatsu, T.Nemoto, *Y.Imamura, Y.Nakamoto: A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype. Clin J Gastroenterol, 8i1j, 18-21, 2015.02iÇ—á•ñj

 

bD‘à

1429009

*H.Okazawa, M.Ikawa, *T.Tsujikawa, *Y.Kiyono, M.Yoneda: Brain imaging for oxidative stress and mitochondrial dysfunction in neurodegenerative disease. Q J Nucl Med Mol Imaging, 58i4j, 387-397, 2014.12, #1.724

 

(2)  ˜a•¶F’˜‘“™iproceedings‚𜂭j

aD’˜‘i•ª’SŽ·•Mj

1429010

ˆäì@³“¹, +•Ä“c@½: MERRF: ™]G•v(‘•ÒW)C•Ÿ“c“~‹GŽqE¼–ìˆêŽOEŒÃ‰ê–õ•q(•ª’S•ÒW)(•Ò): ‘ãŽÓ«ƒ~ƒIƒpƒ`[, f’f‚ÆŽ¡—ÃŽÐ, 175-177, 2014.05

 

1429011

*•Ä“c@½, ˆäì@³“¹, *‰ª‘ò@G•F: 8. ƒp[ƒLƒ“ƒ\ƒ“•a‚¨‚æ‚ÑŠÖ˜A_ŒoŽ¾Š³‚ÌPETŽ_‰»ƒXƒgƒŒƒXƒCƒ[ƒWƒ“ƒO: ‚‹´—Ç•ãAŽ½’J@^AŽR’†G“ñA”óŒû^l(•Ò): ˆâ“`ŽqˆãŠwMOOK 26: ”]“àŠÂ‹«-ˆÛŽ‹@\‚Æ”j’]‚ª‚à‚½‚ç‚·Ž¾Š³Œ¤‹†, 1, ƒƒfƒBƒJƒ‹ ƒhƒD, 212-215, 2014.11

 

1429012

Ö“¡@—L‹I, ¼‰i@»Žq, +•Ä“c@½: ƒgƒLƒ\ƒvƒ‰ƒYƒ}”]‰Š: _ŒoŠ´õÇ‚ð‹†‚ß‚é ƒAƒNƒ`ƒ…ƒAƒ‹ ”]E_ŒoŽ¾Š³‚Ì—Õ°, ’†ŽR‘“X, 240-244, 2014

 

bD–|–ó“™i•ª’S–|–ój

1429013

’†–{@ˆÀ¬(–ó): BŒ^ŠÌ‰Š‚ÌŒŒ´ƒ}[ƒJ[‚ÌŽ©‘RŒo‰ß‚Å‚ÌRŒ´‰A«‰»‚Æ‚»‚ÌŒã‚ÌŠÌ×–EŠà‚̃ŠƒXƒN: GUT“ú–{Œê”ÅVol.6,No.5, WILEY Blackwell, 16-17, 2015.01

 

(3)  ˜a•¶F˜_•¶“™

aDŒ´’˜˜_•¶iR¸—Lj

1429014

–ìã@‘ñl, {“¡@O”V, *¼“c@GŠx, ‚‹´@˜al, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, *¡‘º@DÍ, ’†–{@ˆÀ¬: “àŽ‹‹¾“I”S–Œ‰º‘w”—£p‚ÅØœ‚µ“¾‚½•\ÝŒ^H“¹—ÞŠî’ê×–EŠà‚Ì1—á. “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 111i6j, 1005-1112, 2014.06iÇ—á•ñj

 

1429015

âV“¡@—L‹I, ¼‰i@»Žq, ŽR‘º@C, ˆäì@³“¹, ûM–ì@’‰‘¥, +•Ä“c@½: ”]—À–c‘å•”‰E‘¤[Ç‚É‚æ‚趔¼‘¤‘Š–e•ÏŒ`Ž‹‚ð‚«‚½‚µ‚½¶‚«‚«‚Ì1—á. —Õ°_ŒoŠw, 54i8j, 637-642, 2014.08iÇ—á•ñj

 

1429016

“à“¡@’BŽu, {“¡@O”V, –ìã@‘ñl, ꎓ¡@‹±Žu, ”öú±@‰Ã•F, ‚‹´@˜al, ‘å“¡@˜a–ç, ‘å–ì@’, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, *¡‘º@DÍ, ’†–{@ˆÀ¬: •úŽËü—Ö@‚ª’˜Œø‚µ‚½Helicobacter pyloriœ‹ÛŽ¡—Ã’ïR«’¼’°MALTƒŠƒ“ƒpŽî‚Ì1—á. ENDOSCOPIC FORUM for digestive disease, 30i2j, 131-136, 2014.11iÇ—á•ñj

 

1429017

_àV@•üŽq, ˆäì@³“¹, ûM–ì@’‰‘¥, +‰i“c@”ü˜aŽq, *–Ø‘º@_•F, •Ä“c@½: ”­ÇŽž‚̃Jƒ‹ƒ{ƒLƒVƒwƒ‚ƒOƒƒrƒ“‚ª³í‚Å‚ ‚Á‚½‚ª“ª•”MR spectroscopyŠŒ©‚ªf’f‚ÌŒ_‹@‚Æ‚È‚Á‚½ŠÔŸ[Œ^ˆêŽ_‰»’Y‘f’†“Å‚Ì1—á. —Õ°_ŒoŠw, 54i3j, 234-237, 2014iÇ—á•ñj

 

bD‘à

1429018

’†–{@ˆÀ¬: BŒ^–«ŠÌ‰Š‚ðŽ©‘R”­Ç‚µ‚½ƒ‚[ƒŠƒVƒƒƒX“‡ƒJƒjƒNƒCƒUƒ‹‚Ì”­Œ©‚Æ—Õ°“IˆÓ‹`. Frontiers in Gastroenterology, 19i2j, 46-47, 2014.04

 

1429019

{“¡@O”V, ’†–{@ˆÀ¬: Helicobacter pyloriŠ´õ‚ɑ΂·‚é‘å‹K–Íœ‹ÛŽ¡—Â̗˜“_F’nˆæZ–¯‚ð‘ÎÛ‚Æ‚µ‚½ˆÝŠà—\–h‚ÌŒ¤‹†. Frontiers in Gastroenterology, 19i2j, 48-49, 2014.04

 

1429020

ª–{@•üK, ’†–{@ˆÀ¬: –«ŠÌáŠQ‚É‚æ‚éŠÌ”­Šàƒ‚ƒfƒ‹‚É‚¨‚¢‚Äp53‚Í”ñ×–EŽ©—§“I‚ÉŽîᇗ}§‚É“­‚­. Frontiers in Gastroenterology, 19i2j, 50-51, 2014.04

 

1429021

*•½¼@ŠˆŽu, ’†–{@ˆÀ¬: ’×ᇫ‘å’°‰Š‚É‚¨‚¢‚Ä,GWAS‚ÅŽw“E‚³‚ꂽˆâ“`ŽqÀ‚ðÄ“xƒfƒB[ƒvƒV[ƒNƒGƒ“ƒX‚·‚é‚Æ,CARD9,IL23R,RNF186—̈æ‚ÌŠó­•ÏˆÙ‚ªŽ¾Š³‚ÆŠÖ˜A‚µ‚Ä‚¢‚邱‚Æ‚ª‚í‚©‚Á‚½. Frontiers in Gastroenterology, 19i2j, 52-53, 2014.04

 

1429022

‘å’J@¹O, ’†–{@ˆÀ¬: IgG4ŠÖ˜Ad‰»«’_ŠÇ‰ŠŠ³ŽÒ’_`’†‚Ì‘‰Á‚µ‚½Th2ƒTƒCƒgƒJƒCƒ“‚̓^ƒCƒgƒWƒƒƒ“ƒNƒVƒ‡ƒ“‚É‚æ‚é’_ŠÇã”ç×–EƒoƒŠƒA‚ðáŠQ‚·‚é. Frontiers in Gastroenterology, 19i2j, 54-55, 2014.04

 

1429023

¼‰i@»Žq, •Ä“c@½: ‰“Šu_Œonj󂩂ç‚Ý‚½ˆ««Žîá‡u¬”]«‰^“®Ž¸’²v. ¬l•a‚ƶŠˆKŠµ•a ‚±‚ñ‚È_ŒoÇó‚©‚çŽn‚܂鈫«Žîá‡-–TŽîá‡ÇŒóŒQ‚ÌŽÀ‘Ô-, 44i4j, 401-405, 2014.04

 

1429024

_àV@•üŽq, +•Ä“c@½: ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX_ŒoŠ´õÇ-ƒKƒCƒhƒ‰ƒCƒ“‚ðŠÜ‚ß‚Ä-. ÅVˆãŠwE•Êû V‚µ‚¢f’f‚ÆŽ¡—ÂÌABC 82, 155-166, 2014.04

 

1429025

ª–{@•üK, ’†–{@ˆÀ¬: ŠÌ\¬×–E‚ƖƉu. Hepatology Practice‘æ4Šª@“«ŠÌŽ¾Š³‚Ìf—Âð‹É‚ß‚é@Šî–{‚©‚çÅ‘Oü‚Ü‚Å, 8-11, 2014.05

 

1429026

*rì@Œ’ˆê˜Y, ˆäì@³“¹, +•Ä“c@½: ƒ~ƒgƒRƒ“ƒhƒŠƒAS‹ØÇ‚Æ‘ãŽÓŽ¡—Ã. ŒŽŠ§@×–E, 46i7j, 22-25, 2014.07

 

1429027

’†–{@ˆÀ¬, ª–{@•üK: –Ɖu—Ö@. Hepatology Practice‘æ5Šª@ŠÌŠà‚Ìf—Âð‹É‚ß‚é@Šî–{‚©‚çÅ‘Oü‚Ü‚Å, 5, 328-331, 2014.09

 

1429028

¼‰i@»Žq, •Ä“c@½: bó‘B‹@”\˜´iÇ. •Êû“ú–{—ÕଠV—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.30 _ŒoÇŒóŒQ(‘æ2”Å)V-‚»‚Ì‘¼‚Ì_ŒoŽ¾Š³‚ðŠÜ‚ß‚Ä-, 214-218, 2014.11

 

1429029

‰|–{@’ˆê, ¼‰i@»Žq, •Ä“c@½: bó‘B‹@”\’ቺÇ. •Êû“ú–{—ÕଠV—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.30 _ŒoÇŒóŒQ(‘æ2”Å)V-‚»‚Ì‘¼‚Ì_ŒoŽ¾Š³‚ðŠÜ‚ß‚Ä-, 219-223, 2014.11

 

1429030

*¼“c@GŠx, ’†–{@ˆÀ¬: ŠÌ”^á‡CÅ‹ß‚ÌŽ–î. f’f‚ÆŽ¡—à ŠÌ‘Ÿ•af—ẪAƒbƒvƒf[ƒg, 102i11j, 1701-1705, 2014.11

 

1429031

ûM–ì@’‰‘¥: ‰¡–ä‹Ø—Z‰ðÇ. •Êû“ú–{—ÕଠV—̈æ•ÊÇŒóŒQƒVƒŠ[ƒY‡‚30@_ŒoÇŒóŒQi‘æ2”ÅjV, 30, 598-602, 2014.11

 

1429032

ˆäì@³“¹, •Ä“c@½: MERRF(ÔF‚Ú‚ëüˆÛ‚𔺂¤ƒ~ƒIƒNƒ[ƒkƒX‚Ä‚ñ‚©‚ñÇŒóŒQ). •Êû“ú–{—ÕଠV—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.31 _ŒoÇŒóŒQ(‘æ2”Å)‡Y-‚»‚Ì‘¼‚Ì_ŒoŽ¾Š³‚ðŠÜ‚ß‚Ä-, 345-348, 2014.12

 

1429033

+ŠÛì@—m•½, ’†–{@ˆÀ¬, +Œü“c@’¼Žj, +‹àŽq@Žüˆê: Ž©ŽEˆâ“`ŽqŽ¡—ƒP‹…‘–‰»«ƒ^ƒ“ƒpƒNŽ¿-1. “ú–{—Õ଑Š§† ÅVŠÌŠàŠw-Šî‘b‚Æ—Õ°‚ÌÅVŒ¤‹†“®Œü-, 73i1j, 413-417, 2015.01

 

cD‚»‚Ì‘¼Œ¤‹†“™ŽÀÑi•ñ‘‚ðŠÜ‚Þj

1429034

+”ª‹´@O, ’†–{@ˆÀ¬: 11th Single Topic Conference@’ƒŽR ˆê² ‰ï’·‚É•·‚­. ŠÌ‘Ÿ, 55i7j, 375-377, 2014.07

 

1429035

’†–{@ˆÀ¬: ‹¤“¯Œ¤‹†ŽÒ‚ÌЉî. ‹à‘ò‘åŠw‚ª‚ñi“W§ŒäŒ¤‹†Š News Letter ‘nŠ§†, 8, 2014.10

 

 

 

iBj  Šw‰ï”­•\“™

(1)  ‘ÛŠw‰ï

aDˆê”Êu‰‰iŒû‰‰j

1429036

T.Hamano, N.Shirafuji, +S.H.Yen, *A.Ishida, +Y.Fujita, A.Matsunaga, O.Yamamura, +M.Kuriyama, Y.Nakamoto: ROCK inhibitor decreases phosphorylation levels of tau protein, 26th International Conference of Alzheimer's Association International ConferenceiAAIC 2014), 2014.07, Copenhagen,Denmark

 

1429037

*K.Hiramatsu, *H.Matsuda, M.Ohtani, T.Nemoto, H.Suto, Y.Nakamoto: EFFECTIVENESS AND SAFETY OF ENDOSCOPIC SUBMUCOSAL DISSECTION USING THE BALL-TIP BIPOLARCURRENT NEEDLE KNIFE WITH WATER-JET FUNCTION (JET B-KNIFE) FOR THE TREATMENT OF COLORECTAL TUMORS, 22nd United European Gastroenterology Week, 2014.10, Vienna,Austria

 

bDˆê”Êu‰‰iƒ|ƒXƒ^[j

(1329103)

+T.Yamashita, +A.Kitao, +O.Matsui, +T.Hayashi, +K.Nio, +M.Kondo, +H.Okada, +T.Yamashita, +E.Mizukoshi, +M.Honda, +Y.Nakanuma, +H.Takamura, +T.Ohta, Y.Nakamoto, +M.Yamamoto, +T.Takayama, +S.Arii, +X.Wang, +S.Kaneko: Gd-EOB-DTPA-enhanced MRI and Serum AFP Predict the Prognosis of Early-stage Hepatocellular Carcinoma, The 64th Annual Meeting of the American Association for the Study of Liver Diseases(AASLD2013), 2013.11, Washington, D.C.

 

1429038

A.Matsunaga, T.Kishitani, T.Muramatsu, *T.Kame, M.Ikawa, O.Yamamura, T.Hamano, Y.Nakamoto, +M.Yoneda: Clinical and immunological features of Hashimotofs encephalopathy presenting with limbic symptoms, 2014 AAN, 2014.04, Philadelphia

 

1429039

*M.Hasegawa, +M.Yoshikawa, O.Yamamura, *H.Terasawa: Difficulties identified by at-home care providers working with multidisciplinary professionals, 35‚”‚ˆ International Association for Human Caring Conference, 2014.05, Kyoto(Japan)

 

1429040

+M.Yoshikawa, *M.Hasegawa, O.Yamamura, *H.Terasawa: Difficulties of cooperation recognized by at-home care providers /givers |To clarify the content of trainings about how multidisciplinary professionals work together|, 35‚”‚ˆ International Association for Human Caring Conference, 2014.05

 

1429041

T.Kamisawa, M.Ikawa, +Y.Saito, T.Muramatsu, A.Matsunaga, O.Yamamura, T.Hamano, Y.Nakamoto, +S.Murayama, *H.Okazawa, +M.Yoneda: Pathophysiological decrease in the regional cerebral blood flow in pure autonomic failure with Lewy body, 2014 AAN, 2014.05, Philadelphia

 

1429042

M.Ikawa, *H.Okazawa, *T.Tsujikawa, T.Muramatsu, T.Kishitani, T.Kamisawa, A.Matsunaga, O.Yamamura, *T.Mori, T.Hamano, *Y.Kiyono, Y.Nakamoto, +M.Yoneda: Increased cerebral oxidative stress in amyotrophic lateral sclerosis: a 62Cu-ATSM PET study, 2014 AAN, 2014.05, Philadelphia

 

1429043

*H.Okazawa, M.Ikawa, *T.Tsujikawa, A.Matsunaga, *T.Mori, *Y.Kiyono, *M.Yoneda: Evaluation of cerebral oxidative stress in amyotrophic lateral sclerosis using 62Cu-ATSM PET., The 61st Annual Meeting of The Society of Nuclear Medicine, 2014.06, St. Louis (USA)

 

1429044

+Y.Fujita, T.Hamano, N.Shirafuji, Y.Nakamoto: Chronic cerebral hypoperfusion induces tau hyperphosphorylation accompanied by axonal damage in adult mice, 26th International Conference of Alzheimer's Association International ConferenceiAAIC 2014), 2014.07, Copenhagen,Denmark

 

1429045

*K.Arakawa, M.Ikawa, *H.Tada, *H.Okazawa, +M.Yoneda: The Impact of L-arginine administration in patients with mitochondrial cardiomyopathy evaluated by 11C-acetate-PET, 5th World Congress on Targeting Mitochondria, 2014.10, Berlin,Germany

 

1429046

+M.Yoneda, M.Ikawa, *T.Tsujikawa, *T.Mori, T.Hamano, Y.Nakamoto, *Y.Kiyono, *H.Okazawa: PET imaging of cerebral oxidative stress in neurodegenerative disorders, 5th World Congress on Targeting Mitochondria, 2014.10, Berlin,Germany

 

1429047

T.Naito, +T.Baba, +N.Mukaida, Y.Nakamoto: Cytotoxic CD4+ Cells Play a Pivotal Role in Cyclophosphamide-Mediated Cytotoxicity against Hepatoma without Antigen Priming, The 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014), 2014.11, Boston,Massachusetts

 

1429048

K.Ofuji, +T.Yoshikawa, +Y.Tada, +M.Shimomura, Y.Nakamoto, +T.Nakatsura: Identification of a Novel HLA-A2 Restricted Immunotherapeutic Target Derived from an EGFR Mutated Antigen for the Treatment of Metastatic Liver Tumors, The 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014), 2014.11, Boston,Massachusetts

 

1429049

Y.Nakamoto, +T.Yamashita, *K.Hiramatsu, T.Nemoto, H.Suto, +S.Kaneko: Identification of Hypermethylation and Non-Synonymous Mutations in Genes Down-Regulated during the Process of Hepatocarcinogenesis in a Model of Chronic Hepatitis B, The 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014), 2014.11, Boston,Massachusetts

 

1429050

*H.Matsuda, T.Naito, T.Nosaka, T.Nemoto, M.Ohtani, *K.Hiramatsu, H.Suto, Y.Nakamoto: Serial Changes of Cellular,Humoral,and Innate Immune Responses following Immunosuppressive Chemotherapies Responsible for Hepatitis B Virus Reactivation, The 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014), 2014.11, Boston,Massachusetts

 

1429051

*M.Kubota, O.Yamamura, T.Kamisawa, *C.Igarashi, *Y.Watabe, *S.Shimada, *T.Tsujikawa, *H.Okazawa, +R.Kato, +H.Yokoi, *K.Uchida, *H.Baba: Cortical patterns and functional recovery in chronic stroke patients by functional electrical stimulation, American Society for Neurorehabilitation Annual Meeting 2014, 2014.11, Washington DC (USA)

 

1429052

O.Yamamura, *T.Kamisawa, T.Hamano, Y.Nakamoto, *M.Kubota, *C.Igarashi, *Y.Watabe, *S.Shimada, *H.Okazawa, +R.Kato, +H.Yokoi, *k.Uchida, *H.Baba: Effect of burst stimulation by high frequency biphasic square-wave pulse on cortical perfusion after stroke: A pilot study, American Society for Neurorehabilitation Annual Meeting 2014, 2014.11, Washington DC (USA)

 

1429053

+K.Miyazaki, M.Ikawa, *T.Tsujikawa, *T.Mori, T.Hamano, Y.Nakamoto, *Y.Kiyono, *H.Okazawa, +M.Yoneda: Increased cerebral oxidative stress in amyotrophic lateral sclerosis: a 62Cu-ATSM PET study, The 11th Conference of Asian Society for Mitochondrial Research and Medicine, 2014.11, Taipei,Taiwan

 

1429054

T.Nemoto, *H.Matsuda, T.Nosaka, Y.Saito, Y.Ozaki, T.Naito, K.Takahashi, K.Ofuji, M.Ohtani, *K.Hiramatsu, H.Suto, Y.Nakamoto: Comparison of interferon-alpha combined with hepatic arterial infusion chemotherapy and sorafenib in patients with advanced hepatocellular carcinoma, 2015 Keystone Symposia Conference@Tumor Immunology:Multidisciplinary Science Driving Combination Therapy, 2015.02, Banff,Alberta,Canada

 

(2)  ‘“àŠw‰ïi‘S‘ƒŒƒxƒ‹j

aDµ‘ÒE“Á•Êu‰‰“™

1429055

ûM–ì@’‰‘¥: ŽáŽèˆãŽt‚Ì‚½‚ß‚ÌuŠ´õ‚ƖƉuvƒZƒ~ƒi[ uƒEƒCƒ‹ƒX«‘–Œ‰ŠE”]‰Š‚Ìf’f‚ÆŽ¡—Ãv, ‘æ19‰ñ“ú–{_ŒoŠ´õÇŠw‰ï‘‰ïŠwpW‰ïE‘æ26‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï ‡“¯ŠwpW‰ï, 2014.09, ‹à‘ò

 

1429056

’†–{@ˆÀ¬: Ķˆã—Ó™ˆÀ‘S«Šm•Û–@‚ɑ΂·‚é“–‰@‚Å‚ÌŽæ‚è‘g‚Ý, ‘æ14‰ñ“ú–{Ķˆã—Êw‰ï‘‰ï, ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[4 Ķˆã—Ê֘A–@Ž{sŒã‚̃AƒJƒfƒ~ƒAAŠé‹Æ‚»‚ꂼ‚ê‚ÌŽæ‚è‘g‚Ý, 2015.03, ‰¡•l

 

bDƒVƒ“ƒ|ƒWƒXƒgEƒpƒlƒŠƒXƒg“™

1429057

*‹v•Û“c@‰ëŽj, _àV@•üŽq, *ŒÜ\—’@çH, ŽR‘º@C, *“ˆ“c@½ˆê˜Y, *¼”ö@‰p–¾, *¬£@œA—º, *‰ª‘ò@G•F, +‰Á“¡@—´, +‰¡ˆä@_Žj, *“à“c@Œ¤‘¢, *”nê@‹v•q: 1 ‚©ŒŽŠÔ‚ÌW’†“I‚È‹@”\“I“d‹CŽhŒƒ—Ö@‘OŒã‚̉^“®‹@”\‚Æ”]‹@”\‰æ‘œ‚̕ω»FÇ—á•ñ, ‘æ49‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï, 2014.05, ‰¡•l

 

1429058

*•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: ‰ü—ÇŒ^ƒoƒCƒ|[ƒ‰ØŠJ”—£—pƒiƒCƒt(Jet B knife)‚É‚æ‚é‘å’°ESD`Ž¿‚ÌŒüã‚ƃRƒXƒg‚ðˆÓŽ¯‚µ‚Ä`, ‘æ87‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï, ‘å’°ESD‚Ì“K‰ž‚ÆŽè‹Z, 2014.05, •Ÿ‰ª

 

1429059

{“¡@O”V, +‰Á“¡@‘쎟, ’†–{@ˆÀ¬: H.pyloriœ‹ÛŒã‚̃fƒBƒXƒyƒvƒVƒAÇóCBMI‚Ì’·ŠúŒo‰ß‚ƈݔS–ŒˆÞk‚Æ‚ÌŠÖ˜A, ‘æ88‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï, HPŒ¤‹†‚ÌVŽž‘ã-•a‘Ô¶—‚©‚看ۂ܂Å-, 2014.10, _ŒË

 

1429060

ŽR‘º@C, +A“c@Mô, +ŽÄ“c@@ˆê, +‰““¡@ŒO, +âV“¡@², +ˆî—t@‘, +‰|–{@’ˆê: ˜j—E‘Š‘o’nˆæ‚̉¼ÝZ‘î’c’n‚É‚¨‚¯‚é[•”Ö¬ŒŒðÇ, ‘æ17‰ñ@“ú–{ðŽqŒŸo‚ÆŽ¡—Êw‰ï Embolus2014, Šé‰æƒVƒ“ƒ|ƒWƒEƒ€3@”íÐ’nˆã—Ã, 2014.10, •Ÿ‰ª

 

1429061

*ªÎ@Šgs, *–kˆä@—²•½, ûM–ì@’‰‘¥, *Žl•û@ŽuV, *ŽR“c@^•ã, *ˆéú±@½, *‹´–{@’qÆ, *—L“‡@‰pF, *¬Ž›@rº, *‹e“c@Œ’ˆê˜Y: “Á”­«³íˆ³…“ªÇ‚ƃAƒ‹ƒcƒnƒCƒ}[•a‚ÌMRI‚É‚¨‚¯‚éŠÓ•Ê26Ç—á‚ÌŒŸ“¢, ‘æ73‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï, iNPH ] ƒKƒCƒhƒ‰ƒCƒ“‰ü•Ï‚𓥂܂¦‚Ä, 2014.10, “Œ‹ž

 

cDˆê”Êu‰‰iŒû‰‰j

(1329104)

•Ä“c½, ˆä쳓¹, +´–ìçŒbŽq, *ì’J³’j, *”¨ˆè], *‘O“c_K, *¬â@_—², *“ŒŠÔ³l, *¼–ØFŸ, *˜a“c—LŽi: •Ÿˆä‘åŠwˆâ“`f—Õ”‚ÌŒ»ó‚Ɖۑè, ‘æ58‰ñ“ú–{l—Þˆâ“`Šw‰ï, 2013.11, ‹{é

 

1429062

*‰ª‘ò@G•F, ˆäì@³“¹, *’Òì@“N–ç, *•Ä“c@½, *X@“N–ç, *´–ì@‘×: 62Cu-ATSM PET‚É‚æ‚é‹ØˆÞk«‘¤õd‰»Ç(ALS)‚Ì•]‰¿, ‘æ73‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï, 2014.04, ‰¡•l

 

1429063

ª–{@•üK, *•½¼@ŠˆŽu, *¼“c@GŠx, ‘å’J@¹O, {“¡@O”V, ’†–{@ˆÀ¬: Ž©ŒÈ–Ɖu«ŠÌ‰Šƒ‚ƒfƒ‹‚É‚¨‚¯‚é“]ŽÊ—}§ˆöŽqId2‚ÌŠÖ—^, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï, 2014.05, “Œ‹ž

 

1429064

“à“¡@’BŽu, +”nê@’q‹v, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, *•½¼@ŠˆŽu, +Œü“c@’¼Žj, ’†–{@ˆÀ¬: RŠà‰»Šw—Ö@‚É‚¨‚¯‚éCD4—z«×–EŠQ«TƒŠƒ“ƒp‹…‚É‚æ‚鎩‘R–Ɖu”½‰ž‚ÌŒŸ“¢, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï, 2014.05, “Œ‹ž

 

1429065

*•½¼@ŠˆŽu, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, *”ò“c@ª’j, *–Ø‘º@GŽ÷, +‘]‰Æ@‹`”Ž, ’†–{@ˆÀ¬: CŒ^ŠÌ‰ŠŠ³ŽÒ‚É‚¨‚¯‚éHLA-class‡U—̈æSNPv‘¬‰ðÍ–@‚ÌŠJ”­, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï, 2014.05, “Œ‹ž

 

1429066

‘å“¡@˜a–ç, ’†–{@ˆÀ¬, +’†–Ê@“N–ç: V‹KR‘Ì‚ð—p‚¢‚½ŠÌ‚ª‚ñŒŒ‰tƒ}[ƒJ[‚Æ‚µ‚Ä‚Ì Glypican-3 ŒŸoŒn‚ÌŠJ”­, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï, 2014.05, “Œ‹ž

 

1429067

ûM–ì@’‰‘¥, ”’“¡@–@“¹, +Shu-Hui Yen, —Ñ@_Žk, ¼‰i@»Žq, ŽR‘º@C, +“¡“c@—S”V, +ˆÀì@‘P”Ž, +ŒIŽR@Ÿ, ’†–{@ˆÀ¬: ROCK‘jŠQ–ò‚̃^ƒE’`”’ƒŠƒ“Ž_‰»Ed‡‚É‹y‚Ú‚·‰e‹¿, ‘æ55‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï, 2014.05, •Ÿ‰ª

 

1429068

“à“¡@’BŽu, +”nê@’q‹v, ’†–{@ˆÀ¬, +Œü“c@’¼Žj: ×–EŠQ«CD4+×–E‚̓VƒNƒƒzƒXƒtƒ@ƒ~ƒh‚É‚æ‚éŽîá‡×–EŠQ‚ÉRŒ´”ñˆË‘¶“I‚ÉŠÖ—^‚·‚é, ‘æ73‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï, 2014.09, ‰¡•l

 

1429069

–kú±@—CŽ÷, ŽRŒû@’q‹v, ŽRŽè@NŽi, _àV@•üŽq, ‰|–{@’ˆê, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, *–Ø‘º@_•F, ûM–ì@’‰‘¥: Creutzfeldt Jakob•a‚ÌArterial Spin Labeling(ASL)Ÿó—¬‰æ‘œŠŒ©, ‘æ19‰ñ“ú–{_ŒoŠ´õÇŠw‰ï‘‰ïŠwpW‰ï, 2014.09, ‹à‘ò

 

1429070

*‘O“c@•¶], ª–{@•üK, *ûM“c@•q•F, *‹´–{@‹Vˆê, *‘å’|@—R, *’Óc@—T”üŽq, *Šâ–ì@³”V, *–Ø‘º@GŽ÷, ’†–{@ˆÀ¬: —pŽè“I‰Áˆ³–@‚É‚æ‚éƒGƒ‰ƒXƒgƒOƒ‰ƒtƒB‚ð—p‚¢‚½ƒEƒCƒ‹ƒX«–«ŠÌ‰Š‚É‚¨‚¯‚éŠÌüˆÛ‰»•]‰¿–@‚ÌŒŸ“¢, ‘æ61‰ñ“ú–{—Õ°ŒŸ¸ˆãŠw‰ïŠwpW‰ï, —Õ°ŒŸ¸‚ð‰ÈŠw‚·‚é, 2014.11, •Ÿ‰ª

 

1429071

+²X–Ø@”ü“ÞŽq, ŽR‘º@C, *›’J@ˆŸ¶, *•“c@—L‹IŽq, *”’“¡@–@“¹, *’†‘º@•q–¾, *‰|–{@’ˆê, +’JŒû@–œ’qŽq, +Îã@WŽO: ƒT[ƒrƒX•t‚—îŽÒŒü‚¯Z‘î‹ZŽÒ‚ð‘ÎÛ‚Æ‚µ‚½“d‹CŽg—p—Ê‚Æ…“¹Žg—p—ʂ̉ðÍ‚ÉŠî‚­‚—îŽÒ‹}•Ï—\‘ª‚ÌŒ¤‹†, ‘æ19‰ñ@“ú–{Ý‘îƒPƒAŠw‰ï@Šwp‘å‰ï, 2014.11, •Ÿ‰ª

 

1429072

*’r“c@˜a”ü, ”’“¡@–@“¹, ‘º¼@—ÏŽq, _àV@•üŽq, ã–ì@ˆŸ²Žq, ¼‰i@»Žq, ŽR‘º@C, *¡‘º@DÍ, ûM–ì@’‰‘¥: Lambert]Eaton‹Ø–³—ÍÇŒóŒQ‚ð‡•¹‚µ‚½_ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á, ‘æ32‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï, 2014.11, “Œ‹ž

 

1429073

ŽRŒû@’q‹v, ¼‰i@»Žq, ”’“¡@–@“¹, ‰|–{@’ˆê, ŽRŽè@NŽi, ‘º¼@—ÏŽq, _àV@•üŽq, ŽR‘º@C, ûM–ì@’‰‘¥, *àVˆä@—˜ŽŸ: IVIg—Ö@‚ª‘tŒø‚µ‚½ƒXƒeƒƒCƒh’ïR«‚Å‚ ‚Á‚½–TŽîᇫ‰óŽ€«ƒ~ƒIƒpƒ`[‚Ì1 —á, ‘æ32‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï, 2014.11, “Œ‹ž

 

1429074

ŽR‘º@C: DVTŒŸf‚©‚ç‚Ý‚½‰¼ÝZ‘î’c’n‚É‚¨‚¯‚鶊ˆKŠµ•a‚̕ω», ‘æ20‰ñ@“ú–{W’cЊQˆãŠw‰ï‘‰ïEŠwpW‰ï, 2014.12, “Œ‹ž

 

1429075

ŽR‘º@C: ’Ôg”íÐ’n‚Æ”]‘²’†ŠëŒ¯ˆöŽq@`˜j—ŒSŒ¤‹†`, ‘æ40‰ñ@“ú–{”]‘²’†Šw‰ï‘‰ï, 2015.03, L“‡

 

1429076

ŽR‘º@C, *_àV@•üŽq, *‹v•Û“c@‰ëŽj, *ŒÜ\—’@çH, à_–ì@’‰‘¥, +‰Á“¡@—´, +‰¡ˆä@_Žj, *‰ª‘ò@G•F: V‚½‚ÈŽü”g”‘Ñ‚ð—p‚¢‚½‹@”\“I“d‹CŽhŒƒ—Ö@‚É‚¨‚¯‚é”]‹@”\‰æ‘œ‚̕ω», ‘æ40‰ñ@“ú–{”]‘²’†Šw‰ï‘‰ï, 2015.03, L“‡

 

1429077

*ªÎ@Šgs, *–kˆä@—²•½, ûM–ì@’‰‘¥, *Žl•û@ŽuV, *ŽR“c@^•ã, *“Œ–ì@–FŽj, *ˆéú±@½, *‹´–{@’qÆ, *—L“‡@‰pF, *‹e“c@Œ’ˆê˜Y: “Á”­«³íˆ³…“ªÇ‚Æ”]ŒŒŠÇ«”F’mÇ‚Æ‚ÌMRI‚É‚æ‚éŠÓ•Ê28Ç—á‚Ì”äŠrŒŸ“¢, ‘æ40‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï, 2015.03, L“‡

 

dDˆê”Êu‰‰iƒ|ƒXƒ^[j

1429078

*–ìã@‘ñl, *•½¼@ŠˆŽu, ’†–{@ˆÀ¬: ŠJ• Žèp—ð‚Ì‚ ‚éÇ—á‚É‚¨‚¯‚éPatency capsule‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢, ‘æ100‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï, 2014.04, “Œ‹ž

 

1429079

”’“¡@–@“¹, ûM–ì@’‰‘¥, *Γc@ˆ¤Žq, ¼‰i@»Žq, ã–ì@ˆŸ²Žq, —Ñ@_Žk, ŽR‘º@C, +ŒIŽR@Ÿ, ’†–{@ˆÀ¬: ƒAƒ‹ƒcƒnƒCƒ}[•a‚ƃzƒ‚ƒVƒXƒeƒCƒ“, ‘æ111‰ñ“ú–{“à‰ÈŠw‰ï‘‰ïEu‰‰‰ï, 2014.04, “Œ‹ž

 

1429080

*•“c@—L‹IŽq, ŽR‘º@C, *‰|–{@’ˆê, *”’âÙ@–@“¹, *’†‘º@•q–¾, ûM–ì@’‰‘¥, *—Ñ@Š°”V, *Ž›àV@Gˆê: ƒT[ƒrƒX•t‚«‚—îŽÒZ‘î‚Ì¢‘Ñ•Ê’²¸‚©‚ç‚Ý‚½ˆã—ØAŒg‚Æ•ž–òŠÇ—‚Ì–â‘è, ‘æ5‰ñ“ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ïŠwp‘å‰ï, 2014.05, ‰ªŽR

 

1429081

*¼“c@GŠx, ª–{@•üK, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚É‚¨‚¯‚éBŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚ÌŒ»ó‚ƖƉu—}§E‰»Šw—Ö@Ž{sŽž‚̃TƒCƒgƒJƒCƒ““®‘Ԃ̉ðÍ, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï, 2014.05, “Œ‹ž

 

1429082

*ŒÜ\—’@çH, *‹v•Û“c@‰ëŽj, +_àV@•üŽq, ŽR‘º@C, *‰ª‘ò@G•F, +‰Á“¡@—´, +‰¡ˆä@_Žj, *“ˆ“c@½ˆê˜Y, +”nê@‹v•q: ”]‘²’†Š³ŽÒ‚ɑ΂·‚é“d‹CŽhŒƒ‚𕹗p‚µ‚½‰ºŽˆL“W‰^“®‰Û‘肪”]Šˆ“®‚É—^‚¦‚é‰e‹¿, ‘æ49‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï, 2014.05, ‰¡•l

 

1429083

‚‹´@˜al, {“¡@O”V, ÔàV@—I, ꎓ¡@‹±Žu, “c’†@’mŽq, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, ’†–{@ˆÀ¬: ‚—îŽÒ‚É‚¨‚¯‚éˆÝESDŽ¡—ìт̌Ÿ“¢, ‘æ87‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï, 2014.05, •Ÿ‰ª

 

1429084

‰““¡@–F“¿, —Ñ@_Žk, +ŽRè@–@–¾, +‚”©@–õŽu, +Œüˆä@—TC, +Žá¼@Oˆê, +‰F–ì@‰pˆê: rt-PAÃ’—Ö@‚ðŽ{s‚µ‚½”][ÇÇ—á‚ÉŠÖ‚·‚錟“¢, ‘æ55‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï, 2014.05, •Ÿ‰ª

 

1429085

—Ñ@_Žk, ‰““¡@–F“¿, ¼‰i@»Žq, ŽR‘º@C, +ŒIŽR@Ÿ, ûM–ì@’‰‘¥: ‹Ø‹­’¼«ƒWƒXƒgƒƒtƒB[1Œ^Š³ŽÒ‚Ì㎈‹ØMRIŠŒ©‚Ì“Á’¥, ‘æ55‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï, 2014.05, •Ÿ‰ª

 

1429086

”’“¡@–@“¹, ûM–ì@’‰‘¥, *Γc@ˆ¤Žq, +Shu-Hui Yen, ¼‰i@»Žq, ŽR‘º@C, +ŒIŽR@Ÿ: ƒzƒ‚ƒVƒXƒeƒCƒ“‚É‚æ‚éƒ^ƒE’`”’ƒŠƒ“Ž_‰»Ed‡‘£i‹@˜‚̉ð–¾, ‘æ55‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï, 2014.05, •Ÿ‰ª

 

1429087

+A“c@Mô, +楱‘ò@˜a•F, ŽR‘º@C, +²X–Ø@ˆê—T: ‘å‹K–ÍЊQ‚É‚¨‚¯‚é”][ǂ̃ŠƒXƒNˆöŽq‚Æ‚µ‚ẲºŽˆ[•”Ö¬ŒŒðÇ, ‘æ33‰ñ@“ú–{”]_Œo’´‰¹”gŠw‰ï‘‰ï, 2014.06, ŠâŽè

 

1429088

*‘O“c@_K, *’†àV@‰ëŽq, *“c’†@–ƒ“Þ”ü, *“Œ@•ä, *¬—û@Œ¤Ži, *ŒÜˆä@FŒ›, *•ÐŽR@Š°ŽŸ, *¡‘º@DÍ, •Ä“c@½, *ŽRŒû@–¾•v: ‰Æ‘°«“ûŠà‚Ì—Õ°•a—Šw“IŒŸ“¢, ‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï, 2014.07, ‘åã

 

1429089

‘å“¡@˜a–ç, +‹gì@‘–¾, +‘½“c@DF, +‹g‘º@–ƒ—FŽq, +‰º‘º@^Ø”ü, ’†–{@ˆÀ¬, +’†–Ê@“N–ç: ”ñ¬×–E”x‚ª‚ñ‚É‚¨‚¯‚éEGFR T790M •ÏˆÙ—R—ˆRŒ´‚͖ƉuŒ´«‚ð—^‚¦‚é, ‘æ73‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï, 2014.09, ‰¡•l

 

1429090

ꎓ¡@‹±Žu, {“¡@O”V, ”öú±@‰Ã•F, ‚‹´@˜al, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, ’†–{@ˆÀ¬: ESDŒã’×ᇎ¡–ü‚ð‘J‰„‚³‚¹‚éˆöŽq‚ɂ‚¢‚Ä‚ÌŒŸ“¢, ‘æ88‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï, 2014.10, _ŒË

 

1429091

à_–{@ˆ¤Žq, ª–{@•üK, ”öú±@‰Ã•F, “à“¡@’BŽu, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚É‚¨‚¯‚é”ñB”ñCŒ^ŠÌ×–EŠà‚Ì—Õ°“I“Á’¥‚ÌŒŸ“¢, ‘æ18‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï, 2014.10, _ŒË

 

1429092

“c’†@’mŽq, *•½¼@ŠˆŽu, ‘å“¡@˜a–ç, ‚‹´@˜al, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚É‚¨‚¯‚éƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ““àŽ‹‹¾‚É‚æ‚鬒°ŒŸ¸‚ÌŒ»ó, ‘æ56‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï, 2014.10, _ŒË

 

1429093

—L’Ë@“ÖŽj, ‘å’J@¹O, ‚‹´@˜al, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚ÌIPMNŽèpÇ—á‚É‚¨‚¯‚éäX‰t×–EfEäX‰t’†CEA’l‚ÌŒŸ“¢, ‘æ56‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï, 2014.10, _ŒË

 

1429094

ª–{@•üK, *‘O“c@•¶], *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, *ûM“c@•q•F, *–Ø‘º@GŽ÷, *Šâ–ì@³”V, ’†–{@ˆÀ¬: ƒEƒCƒ‹ƒX«ŠÌ‰Š‚ÌüˆÛ‰»•]‰¿‚É‚¨‚¯‚é’´‰¹”gƒGƒ‰ƒXƒgƒOƒ‰ƒtƒB‚Ì—L—p«‚ÌŒŸ“¢, ‘æ18‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï, 2014.10, _ŒË

 

1429095

–ìã@‘ñl, *¼“c@GŠx, ”öú±@‰Ã•F, “à“¡@’BŽu, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ƒXƒeƒƒCƒh“à•ž—Ö@‚É‚¨‚¯‚éBŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚ÌŒ»ó, ‘æ18‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï, 2014.10, _ŒË

 

1429096

‚‹´@˜al, {“¡@O”V, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, ’†–{@ˆÀ¬: ˆÝESDÇ—á‚É‚¨‚¯‚錌´RƒwƒŠƒRƒoƒNƒ^[EƒsƒƒŠIgGR‘Ì‚ÉŠÖ‚·‚錟“¢, ‘æ56‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï, 2014.10, _ŒË

 

1429097

*ì’J@³’j, ˆäì@³“¹, +´–ì@’qŒbŽq, *‘O“c@_K, •Ä“c@½, *”¨@ˆè]: MLPA–@‚ŃWƒXƒgƒƒtƒBƒ“ˆâ“`Žq‚Ì‹U—z«‚ð’悵‚½1—á, ‘æ59‰ñ“ú–{l—Þˆâ“`Šw‰ï, 2014.11, ]ŒËì‹æ

 

1429098

—Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥: ”­Ç4.5ŽžŠÔˆÈ“à‚ÉMRI-CASL‰æ‘œ‚ðŽB‰e‚µ‚½rt-PAÇ—á‚ÌŒŸ“¢, ‘æ40‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï, 2015.03, L“‡

 

eD‚»‚Ì‘¼

1429099

ŽR‘º@C: ˆê”ÊŒû‰‰8@uƒRƒtƒH[ƒgEIMTE[•”Ö¬ŒŒðv@À’·, ‘æ33‰ñ@“ú–{”]_Œo’´‰¹”gŠw‰ï‘‰ï, 2014.06, ŠâŽè

 

(3)  ‘“àŠw‰ïi’nˆæƒŒƒxƒ‹j

aDµ‘ÒE“Á•Êu‰‰“™

1429100

ŽR‘º@C: ЊQŒ»ê‚©‚ç‚Ý‚¦‚½î•ñ‹¤—L‚ƃPƒAƒ}ƒlƒWƒƒ[‚Ì–ðŠ„, •½¬26”N“xiŽÐj•ŸˆäŒ§‰îŒìŽx‰‡ê–åˆõ‹¦‰ï@‘æ5‰ñŠwp‘å‰ï, 2014.11, •Ÿˆä

 

1429101

‘å’J@¹O: EUS-FNA‚̃Rƒc‚Ɖž—p, ‘æ23‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤ƒZƒ~ƒi[, 2015.01, •xŽR

 

bDƒVƒ“ƒ|ƒWƒXƒgEƒpƒlƒŠƒXƒg“™

1429102

‘å’J@¹O, —L’Ë@“ÖŽj, “c’†@’mŽq, –ìã@‘ñl, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ƒJƒvƒZƒ‹“àŽ‹‹¾ŒŸ¸‚É‚¨‚¯‚éƒpƒeƒ“ƒV[ƒJƒvƒZƒ‹‚Ì—L—p«‚ÌŒŸ“¢, ‘æ103‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤Žx•”—á‰ï, –k—¤‚É‚¨‚¯‚éƒJƒvƒZƒ‹“àŽ‹‹¾‚ÌŒ»‹µ, 2014.06, •Ÿˆä

 

cDˆê”Êu‰‰iŒû‰‰j

(1329105)

”’“¡@–@“¹, ¼‰i@»Žq, *¼–{@ˆ², *Œüˆä@–G, *ìú±@Œö”üŒb, *“yŽR@ŽŽ÷, ŽR‘º@C, ûM–ì@’‰‘¥: ‘Šú‚æ‚è”r”AáŠQ‚ª‚Ý‚ç‚ꂽ–³‹Û«‘–Œ‰Š‚Ì1—á, ‘æ222‰ñ“ú–{“à‰ÈŠw‰ï–k—¤’n•û‰ï, 2014.03, •Ÿˆä

 

1429103

ÔàV@—I, *¼“c@GŠx, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ”dŽí«ŒŒŠÇ“à‹ÃŒÅ‚ð‡•¹‚µ‚½‹‘労õ«ŠÌ”X–E‚Ì1—á, ‘æ223‰ñ“ú–{“à‰ÈŠw‰ï–k—¤’n•û‰ï, 2014.06, ‹à‘ò

 

1429104

*ìK@’qŽm, ‘å’J@¹O, ÔàV@—I, —L’Ë@“ÖŽj, “c’†@’mŽq, –ìã@‘ñl, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: TAE‚ª—LŒø‚Å‚ ‚Á‚½’¼’°GISTŠÌ“]ˆÚ”j—ô‚Ì1—á, ‘æ118‰ñ“ú–{Á‰»Ší•aŠw‰ï–k—¤Žx•”—á‰ï, 2014.06, •Ÿˆä

 

1429105

*’|ì@—S–¢, *•½¼@ŠˆŽu, ÔàV@—I, “c’†@’mŽq, —L’Ë@“ÖŽj, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬, *‘º‰ª@‹Iº, *´…@@ˆê_, *–Ø‘º@_•F: ‘½”­«ŠÌt”X–Eǂɑ΂µ‚ÄŠÌ“®–¬Çðp‚ª—LŒø‚Å‚ ‚Á‚½1—á, ‘æ118‰ñ“ú–{Á‰»Ší•aŠw‰ï–k—¤Žx•”—á‰ï, 2014.06, •Ÿˆä

 

1429106

*’|“à@•¶, ‘å’J@¹O, ÔàV@—I, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, –ìã@‘ñl, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ªŽ¡“IŠÌ×–EŠà‹ÇŠŽ¡—ÃŒã‚É”­Ç‚µ‚½ŒÇ—§«cŠuƒŠƒ“ƒpß“]ˆÚ‚Ìf’f‚ÉEUS-FNA‚ª—L—p‚Å‚ ‚Á‚½1—á, ‘æ103‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤Žx•”—á‰ï, 2014.06, •Ÿˆä

 

1429107

ŽRŒû@’q‹v, ¼‰i@»Žq, ”’“¡@–@“¹, ‰|–{@’ˆê, ŽRŽè@NŽi, ‘º¼@—ÏŽq, _àV@•üŽq, ŽR‘º@C, ûM–ì@’‰‘¥, *àVˆä@—˜ŽŸ: IVIg—Ö@‚ª‘tŒ÷‚µ‚½ƒXƒeƒƒCƒh’ïR«‚Å‚ ‚Á‚½–TŽîᇫ‰óŽ€«ƒ~ƒIƒpƒ`[‚Ì1—á, ‘æ139‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï, 2014.07, –¼ŒÃ‰®

 

1429108

*‘Š–Ø@Fˆò, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, *¡‘º@DÍ, ûM–ì@’‰‘¥: Lambert-Eaton‹Ø–³—ÍÇŒóŒQ‚ð‡•¹‚µ‚½_ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á, ‘æ139‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï, 2014.07, –¼ŒÃ‰®

 

1429109

ŽRŒû@’q‹v, ‰““¡@–F“¿, –kú±@—CŽ÷, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥: ’˜–¼‚È‹N—§«’ጌˆ³‚ð’悵‚½2—á-ƒhƒpƒ~ƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒ^[ƒCƒ[ƒWƒ“ƒO‚É‚æ‚錟“¢-, ‘æ224‰ñ“ú–{“à‰ÈŠw‰ï–k—¤’n•û‰ï, 2014.09, •xŽR

 

1429110

ŽRŒû@’q‹v, —Ñ@_Žk, –kú±@—CŽ÷, ‰““¡@–F“¿, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, ŽR‘º@C, ûM–ì@’‰‘¥, ’†–{@ˆÀ¬: ”xŠàp‘O¸¸Žž‚É”­Œ©‚³‚ꂽ–³ÇŒó«”][Ç‚Ì1—á, ‘æ25‰ñ“ú–{˜V”NˆãŠw‰ï–k—¤’n•û‰ï, 2014.10, ‹à‘ò

 

1429111

*‘Oì@“WœA, ‰““¡@–F“¿, –kú±@—CŽ÷, ŽRŒû@’q‹v, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, +¬’r@tŽ÷, +‰i“c@”ü˜aŽq, ûM–ì@’‰‘¥: _Œo¶ŒŸ‚Åf’f‚µ‚¦‚½‰Æ‘°«ƒAƒ~ƒƒCƒhƒ|ƒŠƒjƒ…[ƒƒpƒ`[(FAP)‚Ì1—á, ‘æ140‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï, 2014.11, •Ÿˆä

 

1429112

*Š|‹´@¸‘¾, ‘å’J@¹O, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, –ìã@‘ñl, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ƒjƒRƒ‰ƒ“ƒWƒ‹‹x–ò‚ª—LŒø‚Å‚ ‚Á‚½“«oŒŒ«¬’°’×ᇂÌ1—á, ‘æ104‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤Žx•”—á‰ï, 2014.11, Îì

 

1429113

*—L‰ê@÷, *•½¼@ŠˆŽu, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: Žá”N’j«‚É”­Ç‚µ‚½“Á”­«’°ŠÇ”X–Eó‹CŽîǂ̈ê—á, ‘æ104‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤Žx•”—á‰ï, 2014.11, Îì

 

1429114

*‘Oì@“WœA, *¼“c@GŠx, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, –ìã@‘ñl, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, *¬—û@Œ¤Ži, *ŽRŒû@–¾•v, ’†–{@ˆÀ¬: ŠÌ“®’‰»Šw—Ö@‚ÆŠÌ“®–¬‰»ŠwÇð—Ö@Ž{sŒã‚ÉØœ‚µ‚½’_ŠÇ“à”­ˆçŒ^ŠÌ×–EŠà‚Ì1—á, ‘æ119‰ñ“ú–{Á‰»Ší•aŠw‰ï–k—¤Žx•”—á‰ï, 2014.11, ‹à‘ò

 

1429115

*a’J@‰Ã¬, ª–{@•üK, –ìã@‘ñl, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: ƒgƒ‹ƒoƒvƒ^ƒ“‚ª—LŒø‚Å‚ ‚Á‚½CŒ^ŠÌd•Ï‚ɇ•¹‚µ‚½‘å—Ê“û‚Ñ• …‚Ì1—á, ‘æ119‰ñ“ú–{Á‰»Ší•aŠw‰ï–k—¤Žx•”—á‰ï, 2014.11, ‹à‘ò

 

1429116

”’“¡@–@“¹, ˆäì@³“¹, ‰““¡@–F“¿, ŠÝ’J@—Z, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥, +¼‘º@—mº, +—é–Ø@d–¾: RHMGCRR‘Ì—z«‰óŽ€«‹Ø‰Š‚Ì1—á, ‘æ141‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï, 2015.03, –¼ŒÃ‰®

 

1429117

–kú±@—CŽ÷, ŽRŒû@’q‹v, ‰““¡@–F“¿, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥: áz¹”­ì‚Å”­Ç‚µASL‰æ‘œ‚ªf’f‚É—L—p‚Å‚ ‚Á‚½d–Œ“®Ã–¬á‘‚Ì1—á, ‘æ141‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï, 2015.03, –¼ŒÃ‰®

 

1429118

*‰F“s‹{@Œd, *¼“c@GŠx, ”öú±@‰Ã•F, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, *“c‹@Ž‹K, *ã“c@F“T, ’†–{@ˆÀ¬: •ÂÇ«‰©át‚Å”­Ç‚µC’´‰¹”gƒKƒCƒh‰ºŽîᇶŒŸ‚É‚æ‚èf’f‚µ“¾‚½ˆ««ƒŠƒ“ƒpŽî‚Ì1—á, ‘æ225‰ñ“ú–{“à‰ÈŠw‰ï–k—¤’n•û‰ï, 2015.03, ‹à‘ò

 

(4)  ‚»‚Ì‘¼‚ÌŒ¤‹†‰ïEW‰ï

aDµ‘ÒE“Á•Êu‰‰“™

1429119

’†–{@ˆÀ¬: BŒ^ŠÌ‰Š‚Æ”­‚ª‚ñ‚Ì•a‘ÔŠw, ‘æ9‰ñŽl‘ŠÌŽ¾Š³Œ¤‹†‰ï, 2014.06, ¼ŽR

 

1429120

’†–{@ˆÀ¬: –«ŠÌ‰Š‚©‚ç”­‚ª‚ñ‚ւ̖Ɖu•a‘ÔŠw, ‘æ6‰ñ•Ÿ“‡Œ§Ž©ŒÈ–Ɖu«ŠÌŽ¾Š³Œ¤‹†‰ï, 2014.11, •Ÿ“‡

 

1429121

’†–{@ˆÀ¬: ŠÌ‚ª‚ñ‚Ì•a‘Ô‚ÆV‚½‚ÈŽ¡—Ãí—ª, ‘æ15‰ñ‰ªŽRŠÌŽ¾Š³Œ¤‹†‰ï, 2015.03, ‰ªŽR

 

bDƒVƒ“ƒ|ƒWƒXƒgEƒpƒlƒŠƒXƒg“™

1429122

’†–{@ˆÀ¬: Treatment of HBV-infected Patients in Japan, 2014 International Symposium on Viral Hepatitis in Asia, 2014.12, Hanoi,Vietnam

 

cDˆê”Êu‰‰iŒû‰‰j

1429123

*•½¼@ŠˆŽu, *¼“c@GŠx, ª–{@•üK, ’†–{@ˆÀ¬: CŒ^ŠÌ‰ŠŠ³ŽÒ‚É‚¨‚¯‚éHLAƒNƒ‰ƒX‡U—̈æSNP‚ÌŒŸ“¢, ‘æ24‰ñRƒEƒCƒ‹ƒX—Ö@Œ¤‹†‰ï‘‰ï, 2014.05, ŽR—œ

 

1429124

*ªÎ@Šgs, *Žl•û@ŽuV, *ŽR“c@^•ã, *ÔàV@ˆ¤‹|, *“Œ–ì@–FŽj, *ˆéú±@½, *‹´–{@’qÆ, *—L“‡@‰pF, *¬Ž›@rº, *–kˆä@—²•½, ûM–ì@’‰‘¥, *‹e“c@Œ’ˆê˜Y: •àsáŠQ‚ªæs‚µ‚½”F’mǂ̈ê—á, ‘æ212‰ñ•Ÿˆä”]_ŒoŽ¾Š³’k˜b‰ï, 2014.05, •Ÿˆä

 

1429125

‰““¡@–F“¿, *‘O“c@–²‹g, *‘Oì@“WœA, –kú±@—CŽ÷, ŽRŒû@’q‹v, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥: ’˜–¼‚È‹N—§«’ጌˆ³‚ð’悵‚½2Ç—á-ƒhƒpƒ~ƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒ^[ƒCƒ[ƒWƒ“ƒO‚É‚æ‚錟“¢-, ‘æ13‰ñ–k—¤ƒp[ƒLƒ“ƒ\ƒ“•aŒ¤‹†‰ï, 2014.06, ‹à‘ò

 

1429126

ŽRŒû@’q‹v, –kú±@—CŽ÷, ‰““¡@–F“¿, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥, ’†–{@ˆÀ¬: Ä”­‚ðŒJ‚è•Ô‚µ‚½SŒ´«”]ÇðÇ‚Ì1—á, ‘æ514‰ñ•ŸˆäŒ§“à‰È—Õ°§˜b‰ï, 2014.09, •Ÿˆä

 

1429127

“à“¡@’BŽu, +Œü“c@’¼Žj, ’†–{@ˆÀ¬: ŠÌŠà‰»Šw—Ö@‚ÌRŽîᇌø‰Ê‚É‚¨‚¯‚éCD4(+)CTL‚ÌŠÖ—^, ‘æ25‰ñThe Meeting of Liver and Immunology, 2014.09, ‹ž“s

 

1429128

ª–{@•üK: ŠÌ«”]LJ•¹ŠÌd•ÏŠ³ŽÒ‚ɑ΂·‚éƒJƒ‹ƒjƒ`ƒ“‚Ì—L—p«‚ÌŒŸ“¢, ‘æ4‰ñ•ŸˆäŠÌ‘Ÿ‰h—{ƒtƒH[ƒ‰ƒ€, 2014.09, •Ÿˆä

 

1429129

”öú±@‰Ã•F, {“¡@O”V, –ìã@‘ñl, ꎓ¡@‹±Žu, “à“¡@’BŽu, ‚‹´@˜al, ‘å“¡@˜a–ç, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, *¡‘º@DÍ, ’†–{@ˆÀ¬: ESD‚ÅŽ¡–ü‚µ‚¦‚½30Αä‚É”­Ç‚µ‚½Helicobacter pylori‰A«’°Œ^•ª‰»Œ^ˆÝŠà‚Ì1—á, ‘æ7‰ñ…å‚̉ï`‘æ18‰ñÁ‰»ŠíŠwpƒZƒ~ƒi[`, 2014.09, •Ÿˆä

 

1429130

‘å“¡@˜a–ç, +‹gì@‘–¾, +‘½“c DF, +‹g‘º –ƒ—FŽq, +‰º‘º ^Ø”ü, ’†–{@ˆÀ¬, +’†–Ê “N–ç: “]ˆÚ«ŠÌŽîᇂɑ΂·‚éV‹KHLA-A2S‘©«EGFR•ÏˆÙ—R—ˆ•W“IRŒ´‚Ì“¯’è, ‘æ7‰ñ…å‚̉ï`‘æ18‰ñÁ‰»ŠíŠwpƒZƒ~ƒi[`, 2014.09, •Ÿˆä

 

1429131

*¼“c@GŠx, “à“¡@’BŽu, –ìã@‘ñl, ª–{@•üK, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: BŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚̃ŠƒXƒN‚ð—L‚·‚é–Ɖu—}§E‰»Šw—Ö@‚É‚¨‚¯‚éAŒŒ´ƒTƒCƒgƒJƒCƒ““®‘Ԃ̉ðÍ, ‘æ7‰ñ…å‚̉ï`‘æ18‰ñÁ‰»ŠíŠwpƒZƒ~ƒi[`, 2014.09, •Ÿˆä

 

1429132

*•½¼@ŠˆŽu, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ‘å’°ESD‚É‚¨‚¯‚éV‹KƒoƒCƒ|[ƒ‰Œ^ØŠJ”—£ƒfƒoƒCƒXAƒWƒFƒbƒgB-ƒiƒCƒt‚Ì—L—p«‚ÌŒŸ“¢, ‘æ7‰ñ…å‚̉ï`‘æ18‰ñÁ‰»ŠíŠwpƒZƒ~ƒi[`, 2014.09, •Ÿˆä

 

1429133

*ˆéú±@½, *—L“‡@‰pF, *ªÎ@Šgs, *Žl•û@ŽuV, *ŽR“c@^•ã, *“Œ–ì@–FŽj, *‹´–{@’qÆ, *¬Ž›@rº, *–kˆä@—²•½, ŠÝ’J@—Z, ûM–ì@’‰‘¥, *–Ø‘º@_•F, *‹e“c@Œ’ˆê˜Y: ŠC–ÈÖ¬“´•”d–Œ“®Ã–¬á‘(CSdAVF)‚É‚¨‚¯‚éASL•]‰¿, ‘æ29‰ñ•ŸˆäŒ§”]‹@”\‰æ‘œƒJƒ“ƒtƒ@ƒŒƒ“ƒX, 2014.10, •Ÿˆä

 

1429134

{“¡@O”V: H.pyloriœ‹ÛŒã‚̃fƒBƒXƒyƒvƒVƒAÇóABMI‚Ì’·ŠúŒo‰ß, ‘æ1‰ñ•ŸˆäÁ‰»Ší•aƒtƒH[ƒ‰ƒ€, 2014.12, •Ÿˆä

 

1429135

ŽRŒû@’q‹v, —Ñ@_Žk, ûM–ì@’‰‘¥: ¶–[”S‰tŽîC¶SŽ¨“àŒŒð‚ªŒ´ˆö‚Æl‚¦‚ç‚ꂽSŒ´«”]ÇðÇ‚Ì1—á, ‘æ216‰ñ•Ÿˆä”]E_ŒoŽ¾Š³’k˜b‰ï, 2015.01, •Ÿˆä

 

1429136

–kú±@—CŽ÷, ŽRŒû@’q‹v, ‰““¡@–F“¿, ŽRŽè@NŽi, _àV@•üŽq, ŠÝ’J@—Z, ”’“¡@–@“¹, ‰|–{@’ˆê, ¼‰i@»Žq, —Ñ@_Žk, *–Ø‘º@_•F, ŽR‘º@C, ûM–ì@’‰‘¥: ŒÇ”­«Creutzfeldt-Jakob•a‚ÌASLŸó—¬‰æ‘œŠŒ©, ‘æ30‰ñ•ŸˆäŒ§”]‹@”\‰æ‘œƒJƒ“ƒtƒ@ƒŒƒ“ƒX, 2015.03, •Ÿˆä

 

dDˆê”Êu‰‰iƒ|ƒXƒ^[j

1429137

”öú±@‰Ã•F, ª–{@•üK, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚É‚¨‚¯‚é”ñƒAƒ‹ƒR[ƒ‹«Ž‰–b«ŠÌ‰Š(NASH)‚ð”wŒi‚Æ‚µ‚½ŠÌ×–EŠà‚Ì—Õ°•a—Šw“I“Á’¥‚ÌŒŸ“¢, ‘æ50‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï, 2014.06, ‹ž“s

 

 

 

4D  ƒOƒ‰ƒ“ƒgŽæ“¾@@

iAj  ‰ÈŒ¤”ïEŒ¤‹†•¬‹à“™

‹æ•ª

Œ¤‹†Ží–Ú

‰Û@‘è@–¼

‘ã•\ŽÒ–¼

•ª’SŽÒ–¼

Šú@ŠÔ

i”N“xj

‹à@Šz

i”z•ªŠzj

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(B)iˆê”Êj

ŠÌ‘Ÿ‚Ì–«‰ŠÇ‚ª—U“±‚·‚é”­‚ª‚ñŒó•âˆâ“`Žq‚É‚¨‚¯‚éƒhƒ‰ƒCƒo[•ÏˆÙ‚Ì“¯’è

’†–{@ˆÀ¬

 

2014

5,850ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

’§í“I–G‰èŒ¤‹†

ƒ}ƒCƒNƒƒLƒƒƒrƒeƒBƒAƒŒƒC‰t‘̶ŒŸ‹Zp‚ð—p‚¢‚½ŠÌ‚ª‚ñÄ”­’´‘Šúf’f–@‚ÌŠJ”­

’†–{@ˆÀ¬

 

2014

1,430ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(C)iˆê”Êj

ƒ^ƒE’`”’ƒIƒŠƒSƒ}[‚ª—U“±‚·‚éƒAƒ‹ƒcƒnƒCƒ}[•a‚Ì•ªŽq‹@˜‚̉ð–¾@—Õ°‚ւ̉ž—p

à_–ì@’‰‘¥

”’“¡@–@“¹

2014

1,560ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(C)iˆê”Êj

ˆÝ”­Šà‚ð§Œä‚·‚éH•i‚̃GƒsƒWƒFƒlƒeƒBƒNƒX‹@\‚̉ðÍ

{“¡@O”V

’†–{@ˆÀ¬

2014

1,950ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

’§í“I–G‰èŒ¤‹†

ŠÌƒGƒlƒ‹ƒM[‘ãŽÓ‚ÉŠÖ—^‚·‚éV‹K“]ŽÊ—}§ˆöŽq‚Ì‹@”\‰ðÍ‚Æ‘ãŽÓŠÖ˜AŠÌŽ¾Š³Ž¡—Âւ̉ž—p

ª–{@•üK

 

2014

1,300ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(B)iˆê”Êj

kЂɂæ‚鉼àZ‘î‹ZŽÒ‚̃‚ƒrƒŠƒeƒB‚ÆŒ’N‚ÉŠÖ‚·‚錤‹†

+Œ³“c@—ÇF

ŽR‘º@C

2014

650ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(C)iˆê”Êj

’Ôg”íÐ’n‚ðƒtƒB[ƒ‹ƒh‚Æ‚µ‚½‰ºŽˆÃ–¬ƒGƒR[ŠŒ©‚ÆŽ~ŒŒ‹@”\ŒŸ¸‚ÌŒ¤‹†

ŽR‘º@C

 

2014

1,170ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

ŽáŽèŒ¤‹†(B)

•Ó‰Œn”]‰ŠŒ^‹´–{”]Ç‚Ì—Õ°‘œ‚Æ•a‘Ô‹@˜‚̉ð–¾

¼‰i@»Žq

 

2014

1,690ç‰~

‘–±È–k—¤‘‡’ÊM‹Ç‹£‘ˆ“IŽ‘‹à

í—ª“Iî•ñ’ÊMŒ¤‹†ŠJ”­„i§“x(SCOPE)

Ý‘îˆã—ÂƉîŒì‚ׂ̈̃Aƒ‰[ƒ€ƒAƒhƒoƒCƒU[Žx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†ŠJ”­

ŽR‘º@C

”’“¡@–@“¹

‰|–{@’ˆê

2014

6246.682ç‰~

‘–±Èî•ñ’ÊM‘Ûí—ª‹Ç‹£‘ˆ“IŽ‘‹à

í—ª“Iî•ñ’ÊMŒ¤‹†ŠJ”­„i§“x(SCOPE)

“ü—ÍŒ^BMI“d‹CŽhŒƒ‚ð—p‚¢‚½‰^“®‚ÆŠ´Šo‚ÌĶ–@‚ÌŒ¤‹†ŠJ”­

ŠÝ’J@—Z

 

2014

3952ç‰~

Œú¶˜J“­È‰ÈŠw

Œ¤‹†”ï•â•‹à

BŒ^ŠÌ‰Š‘n–òŽÀ—p‰»“™Œ¤‹†Ž–‹Æ

HBV cccDNA‚̧Œä‚Æ”rœ‚ð–ÚŽw‚·V‹K–ƉuŽ¡—Öò‚ÌŠJ”­

+‹àŽq@Žüˆê

’†–{@ˆÀ¬

2014

3,500ç‰~

Œú¶˜J“­È‰ÈŠw

Œ¤‹†”ï•â•‹à

ŠÌ‰Š“™Ž•ž‹Ù‹}‘ÎôŒ¤‹†Ž–‹Æ

ŽŸ¢‘ãƒV[ƒNƒGƒ“ƒX‹Zp‚ð‹ìŽg‚µ‚½ƒEƒCƒ‹ƒXƒQƒmƒ€‰ðÍ‚É‚æ‚éCŒ^ŠÌ‰Š‚Ì•a‘ԉ𖾂Ɨհ‰ž—p

+‰|–{@MK

’†–{@ˆÀ¬

2014

2,000ç‰~

Œú¶˜J“­È‰ÈŠw

Œ¤‹†”ï•â•‹à

ŠÌ‰Š“™Ž•ž‹Ù‹}‘ÎôŒ¤‹†Ž–‹Æ

‚aŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXeR‘Ì—z«–³ÇŒó«ƒLƒƒƒŠƒA‚Ì’·Šú—\Œã‚ÉŠÖ‚·‚錟“¢

+‰¡{‰ê@Žû

’†–{@ˆÀ¬

2014

1,000ç‰~

Œú¶˜J“­È‰ÈŠw

Œ¤‹†”ï•â•‹à

“«Ž¾Š³­ôŒ¤‹†Ž–‹Æ

ƒXƒ‚ƒ“‚ÉŠÖ‚·‚é’²¸Œ¤‹†

+¬’·’J@³–¾

ûM–ì@’‰‘¥

2014

700ç‰~

Šw“à‹£‘ˆ“IŽ‘‹à

‹£‘ˆ“I”z•ªŒo”ïE‹³ˆç

æiˆã—ÃV[ƒYuƒsƒ^ƒoƒXƒ^ƒ`ƒ“‚̃Aƒ‹ƒcƒnƒCƒ}[•aŽ¡—Âւ̉ž—pv

à_–ì@’‰‘¥

 

2014

300ç‰~

Šw“à‹£‘ˆ“IŽ‘‹à

‹£‘ˆ“I”z•ªŒo”ïE‹³ˆç

•½¬26”N“x@u’ni’mj‚Ì‹’“_®”õŽ–‹Æi‘åŠwCOCŽ–‹Æj

*’·’Jì@”ü

ŽR‘º@C

2014

753ç‰~

Šw“à‹£‘ˆ“IŽ‘‹à

‚»‚Ì‘¼

‚ƒzƒ‚ƒVƒXƒeƒCƒ“ŒŒÇ‚É‚æ‚éƒp[ƒLƒ“ƒ\ƒ“•aƒ¿ƒVƒkƒNƒŒƒCƒ“d‡‘£i‹@\‚̉ð–¾

ûM–ì@’‰‘¥

”’“¡@–@“¹

2014

200ç‰~

 

 

 

iBj  §ŠwŠñ•‹à

Žó“üŒ”

38@Œ

Žó“ü‹àŠz

25,735,640@‰~

 

 

 

5D  ‚»‚Ì‘¼‚ÌŒ¤‹†ŠÖ˜AŠˆ“®

iAj  Šw‰ïŠJÓ™

‹æ•ª

ŽåÃE‹¤Ã‚Ì•Ê

Šw‰ï–¼

ŠJÓú

ŠJÃ’n

‘“àŠw‰ï(’n•ûƒŒƒxƒ‹)

ŽåÃŽÒ

‘æ9‰ñ“à‰Èˆã‚ð–ÚŽw‚·ŽáŽèˆãŽt‚Ì‚½‚ß‚Ì‹³ˆçƒZƒ~ƒi[u“à‰ÈŠw‚Ì–¢—ˆ‚ð肤v

2014.11.29

‹à‘ò

 

 

 

iBj  Šw‰ï‚ÌŽÀÑ

Šw‰ï‚Ì–¼Ì

–ðE–¼

Ž–¼

“ú–{“à‰ÈŠw‰ï

•]‹cˆõ

’†–{ ˆÀ¬

“ú–{“à‰ÈŠw‰ï

–k—¤Žx•”•]‹cˆõ

’†–{ ˆÀ¬

“ú–{Á‰»Ší•aŠw‰ï

à’c•]‹cˆõ

’†–{ ˆÀ¬

“ú–{Á‰»Ší•aŠw‰ï

–k—¤Žx•”•]‹cˆõ

’†–{ ˆÀ¬

“ú–{ŠÌ‘ŸŠw‰ï

•]‹cˆõ

’†–{ ˆÀ¬

“ú–{ŠÌ‘ŸŠw‰ï

¼•”‰ï•]‹cˆõ

’†–{ ˆÀ¬

“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï

–k—¤Žx•”•]‹cˆõ

’†–{ ˆÀ¬

“ú–{Á‰»Ší–ƉuŠw‰ï

•]‹cˆõ

’†–{ ˆÀ¬

“ú–{_ŒoŽ¡—Êw‰ï

•]‹cˆõ

à_–ì ’‰‘¥

“ú–{_ŒoŠ´õÇŠw‰ï

•]‹cˆõ

à_–ì ’‰‘¥

“ú–{_ŒoŠw‰ï

‘ã‹cˆõ

à_–ì ’‰‘¥

”F’è“à‰ÈŠw‰ïê–åˆã•”‰ï

–k—¤Žx•”‘ã•\/–k—¤Žx•”–ðˆõ

à_–ì ’‰‘¥

“ú–{Á‰»Ší•aŠw‰ï

Šw‰ï•]‹cˆõ

{“¡ O”V

“ú–{Á‰»Ší•aŠw‰ï

–k—¤Žx•”•]‹cˆõ

{“¡ O”V

“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï

–k—¤Žx•”•]‹cˆõ

{“¡ O”V

“ú–{Á‰»Ší•aŠw‰ï

–k—¤Žx•”•]‹cˆõ

ª–{ •üK

“ú–{ðŽqŒŸo‚ÆŽ¡—Êw‰ï

•]‹cˆõ

ŽR‘º C

“ú–{”]_Œo’´‰¹”gŠw‰ï

•]‹cˆõ

ŽR‘º C

“ú–{Á‰»Ší•aŠw‰ï

–k—¤Žx•”•]‹cˆõ

‘å’J ¹O

“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï

–k—¤Žx•”•]‹cˆõ

‘å’J ¹O

 

 

 

iCj  ‚»‚Ì‘¼

ƒŽóÜ„

·  *‹v•Û“c@‰ëŽj, ŽR‘º@C, _àV@•üŽq, *ŒÜ\—’@çH, *¼”ö@‰p–¾, *¬£@œA—º, *“ˆ“c@½ˆê˜Y, +‰Á“¡@—´, +‰¡ˆä@_Žj, *“à“c@Œ¤‘¢, *”nê@‹v•q: —Šw—Ö@Šw‘æ41ŠªŒ¤‹†˜_•¶Å—DGÜiŒö‰vŽÐ’c–@l@“ú–{—Šw—Ö@Žm‹¦‰ïj, 2015.03

ƒ•ñ“¹„

·  à_–ì@’‰‘¥: g‚Ó‚­‚¢‚̃hƒNƒ^[‘Š’kŽºhオŸŽè‚ɉñ‚èAŒû‚©‚ç˜Io, •Ÿˆä, 2014.04.17

·  ŽR‘º@C: ƒGƒRƒmƒ~[ƒNƒ‰ƒXÇŒóŒQ@—\–hŒŸf, NHKƒjƒ…[ƒX‚¨‚͂悤“ú–{@iNHKŠâŽèj, 2014.05.11

·  —Ñ@_Žk: gŒ³‹C‚ňケ‚¤h”]‘²’†‚ÌŽ¡—Â͈ê‚à‘‚­, Œ§–¯•Ÿˆä, 2014.06.08

·  ŽR‘º@C: ‹³ŒP‚ð¡‚Éc•Ÿˆä‹‰J10”N, ƒCƒ“ƒ^ƒrƒ…[, •ŸˆäƒeƒŒƒr@ƒX[ƒp[ƒjƒ…[ƒX, 2014.07.09

·  ª–{@•üK: gŒ³‹C‚ňケ‚¤hŠÌ‘Ÿ‚ª‚ñ‚ÌÅVŽ¡—Ã, Œ§–¯•Ÿˆä, 2014.07.27

·  ŽR‘º@C: ”ð“ɒiƒ{[ƒ‹ƒxƒbƒh, •Ÿˆä, 2014.08.28

·  ŽR‘º@C: ЊQŽž‚Ì”ð“ïŠuƒXƒy[ƒXL‚­v, Œ§–¯•Ÿˆä, 2014.09.08

·  {“¡@O”V: H.pyloriœ‹ÛŒã‚̃fƒBƒXƒyƒvƒVƒAÇó‚ÆBMI‚̕ω», Medical Tribune, 2014.12.11

·  ŽR‘º@C: •Ÿˆä‘åEŽR‘ºˆãŽt‚ª’ñ¥ ‚—îŽÒЊQŠÖ˜AŽ€–h‚°, “Ç”„, 2015.01.17

·  ŽR‘º@C: ”íÐŽÒŽx‰‡‚ÌŒ®‚Í‘½•ª–ì˜AŒg, L“‡“y»ÐŠQ‚𓥂܂¦A”íÐŽÒŽx‰‡‚ÌÝ‚è•û‚ð’T‚éƒVƒ“ƒ|ƒWƒEƒ€‚ɂ‚¢‚Ä, ’†‘V•·, 2015.01.26

·  ûM–ì@’‰‘¥: gŒ³‹C‚ňケ‚¤h‘–Œ‰Š, Œ§–¯•Ÿˆä, 2015.02.22

·  ŽR‘º@C: ƒVƒŠ[ƒY‚ ‚·‚Ö”õ‚¦‚é@‚—îŽÒŒ©Žç‚èƒVƒXƒeƒ€, Ý‘îˆã—ÂƉîŒì‚ׂ̈̃Aƒ‰[ƒ€ƒAƒhƒoƒCƒU[Žx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†‚ɂ‚¢‚Ä, NHK•Ÿˆä•ú‘—‹Ç, 2015.02.26

·  ŽR‘º@C: ƒT[ƒrƒX•t‚«‚—îŽÒZ‘î “ü‹ŽÒ‚ÌŒ’NŠO‚©‚çŠm”F, •Ÿˆä, 2015.03.05

·  ûM–ì@’‰‘¥: g”F’mÇ‚ðŽx‚¦‚é•Ÿˆä‚ÌŽ‹“_h‰º@’nˆæ‚Å•é‚ç‚·‚½‚ß‚ÉŒ§“àê–åˆã‚É•·‚­, •Ÿˆä, 2015.03.26

 

 

 

6D  ŽY‹ÆEŽÐ‰ï‚Ö‚ÌvŒ£

iAj  ‘E’nˆæ“™‚Ö‚ÌvŒ£

(1)  R‹c‰ïEˆÏˆõ‰ïEŒö‰v–@lE‰ïŽÐ“™‚Ö‚ÌŽQ‰Áó‹µ

‹æ•ª

‹@ŠÖEˆÏˆõ‰ï‚Ì–¼Ì“™

–ðE

Ž–¼

ŠúŠÔ

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§“à‰Èˆã‰ï

ŒÚ–â

’†–{@ˆÀ¬

2011.04`

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§Œ’N•ŸŽƒ•”

ˆÏˆõ

’†–{@ˆÀ¬

2013.04.01`2015.03.31

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§ˆãŽt‰ï, •ŸˆäŒ§ˆãŽt‰ïˆã—ÃVƒXƒeƒ€ˆÏˆõ‰ï

ˆÏˆõ

’†–{@ˆÀ¬

2013.08`2015.06

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§’è”N—î”F’mÇŒŸfŒŸ“¢•”‰ï

ˆÏˆõ

à_–ì@’‰‘¥

2012`

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§‘–¯Œ’N•ÛŒ¯f—ÕñVR¸ˆÏˆõ‰ï

ˆÏˆõ

{“¡@O”V

2012.06`2014.08

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§‚ª‚ñŒŸf¸“xŠÇ—ˆÏˆõ‰ï

ˆÏˆõ

{“¡@O”V

2012.10`

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§‚ª‚ñf—ØAŒg‹¦‹c‰ï, ˆÝ‚ª‚ñ’nˆæ˜AŒgƒpƒXESDƒ[ƒLƒ“ƒO‰ï‹c

ˆÏˆõ

{“¡@O”V

2014.09`

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§Œ’N•ŸŽƒ•”’nˆæˆã—ÉÛ, ’nˆæˆã—ØAŒgƒVƒXƒeƒ€\’zŒŸ“¢‰ï

ˆÏˆõ

ŽR‘º@C

2010.07`

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§•ŸˆäŒ’N•ŸŽƒƒZƒ“ƒ^[, •ŸˆäEâˆä’nˆæˆã—ØAŒgEÝ‘îˆã—Äi‹¦‹c‰ï

ˆÏˆõ

ŽR‘º@C

2011.01`

’n•ûŽ©Ž¡‘Ì

•ŸˆäŒ§Œ’N•ŸŽƒ•”

ê–å•”‰ïˆãˆõ

ŽR‘º C

2013.04.01`2018.03.31

Œö‰v–@l“™

“ú–{ŠwpU‹»‰ï

ê–åˆÏˆõ

’†–{@ˆÀ¬

2013.12.01`2014.11.30

‚»‚Ì‘¼

(ŽÐ)•ŸˆäŒ§ˆãŽt‰ï

ˆÏˆõ

’†–{@ˆÀ¬

2013.08.01`2015.06.30

‚»‚Ì‘¼

•ŸˆäŒ§Œ’N•ŸŽƒ•”

ˆÏˆõ

ûM–ì@’‰‘¥

2013.04.20`2015.04.19

‚»‚Ì‘¼

•ŸˆäŒ§ˆãŽt‰ï, •ŸˆäŒ§ˆãŽt‰ï—«ˆãŽt‘ÎôˆÏˆõ‰ï

ˆÏˆõ

ŽR‘º@C

2013.08`2015.06

‚»‚Ì‘¼

•ŸˆäŒ§ˆãŽt‰ï, •ŸˆäŒ§ˆãŽt‰ï‚ª‚ñ“o˜^E”]‘²’†“o˜^ˆÏˆõ‰ï

ˆÏˆõ

ŽR‘º@C

2013.08`2015.06

‚»‚Ì‘¼

•ŸˆäŒ§—§•a‰@, •ŸˆäŒ§—§•a‰@ˆã—Ãî•ñƒVƒXƒeƒ€XV‹Æ–±ˆÏ‘õ‚ÉŠÖ‚·‚éR¸ˆÏˆõ‰ï

ˆÏˆõ

ŽR‘º@C

2015.02`2015.03

 

 

 

(2)  ŽÐ‰ïl“™‚Ö‚ÌvŒ£‹y‚ÑŠwZ“™‚Ƃ̘AŒgE‹¦—Í‚É‚æ‚銈“®

‹æ•ª

Šˆ“®–¼EŠˆ“®“à—e

ŽåÃŽÒE‘ÎÛŽÒ“™

Ž–¼

ŒöŠJuÀ

Žs–¯ŒöŠJuÀ ŠÌ‚ª‚ñ–o–ŃtƒH[ƒ‰ƒ€2014uƒCƒ}ƒhƒL‚ÌŠÌ‘Ÿ‚ª‚ñv, BŒ^ŠÌ‰Š‚Æ‚ª‚ñ

(ˆêŽÐ)“ú–{ŠÌ‘ŸŠw‰ï, ˆê”Ê

’†–{@ˆÀ¬

ŒöŠJuÀ

Žs–¯ŒöŠJuÀ ŠÌ‚ª‚ñ–o–ŃtƒH[ƒ‰ƒ€2014uƒCƒ}ƒhƒL‚ÌŠÌ‘Ÿ‚ª‚ñv, ŠÌ‘Ÿ‚ª‚ñ

(ˆêŽÐ)“ú–{ŠÌ‘ŸŠw‰ï, ˆê”Ê

ª–{@•üK

ŒöŠJuÀ

‚“xê–åE‹Ælˆç¬, Ý‘îˆã—ÃvƒƒtƒFƒbƒVƒ‡ƒiƒ‹uÀ

•Ÿˆä‘åŠw, ê–åE‹Æl, 130l

*’·’Jì@”ü, ŽR‘º@C, *•“c@—L‹IŽq

u‰‰EƒZƒ~ƒi[“™

lŠÔ‰ÈŠw“Á•Êu‹`, –¢—ˆˆã—Âɂ¨‚¯‚é—Ï—«

Î쌧—§‹à‘òò‹u‚“™ŠwZ, ‚Z¶, 41l

’†–{@ˆÀ¬

u‰‰EƒZƒ~ƒi[“™

âˆä’n‹æŠwpu‰‰‰ï, ƒEƒCƒ‹ƒX«ŠÌ‰Š‚ɑ΂·‚鎡—Ã`ƒCƒ“ƒ^[ƒtƒFƒƒ“‚©‚çŒoŒûÜ‚Ö`

âˆä’n‹æˆãŽt‰ïAƒuƒŠƒXƒgƒ‹Eƒ}ƒCƒ„[ƒYŠ”Ž®‰ïŽÐ, ê–åE‹Æl

’†–{@ˆÀ¬

u‰‰EƒZƒ~ƒi[“™

‘æ173‰ñ‰œ‰zŠwpu‰‰‰ï, ƒEƒCƒ‹ƒX«ŠÌ‰Š‚ɑ΂·‚鎡—Ã`ƒCƒ“ƒ^[ƒtƒFƒƒ“‚©‚çŒoŒûÜ‚Ö`

‘å–ìŽsˆãŽt‰ïAŸŽRŽsˆãŽt‰ïAƒuƒŠƒXƒgƒ‹Eƒ}ƒCƒ„[ƒYŠ”Ž®‰ïŽÐ, ê–åE‹Æl

’†–{@ˆÀ¬

u‰‰EƒZƒ~ƒi[“™

‘Ûƒ]ƒ“ƒ^•Ÿˆäƒ]ƒ“ƒ^ƒNƒ‰ƒu@‘æ24‰ñŒ’Nu‰‰‰ï, ’m‚Á‚Ä‚¨‚«‚½‚¢u”F’mÇ—\–h‚Æ”­Ç‚µ‚½•û‚ւ̑Έ–@v

‘Ûƒ]ƒ“ƒ^•Ÿˆäƒ]ƒ“ƒ^ƒNƒ‰ƒu, ˆê”Ê, 110l

à_–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

—ä–k”F’mÇŽ¾Š³ˆã—ÃZƒ“ƒ^[Œ¤C‰ïuÅ‹ß’–Ú‚³‚ê‚é”F’mÇ ”F’mÇ‚ÌV‚µ‚¢“WŠJv, Å‹ß’–Ú‚³‚ê‚é”F’mÇ

—ä–k”F’mÇŽ¾Š³ˆã—ÃZƒ“ƒ^[E•ŸˆäŽsE•ŸˆäŽsˆãŽt‰ï, ê–åE‹Æl

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

”F’mǃtƒH[ƒ‰ƒ€ in •Ÿˆä, •ŸˆäŒ§’è”N—f‚ÌŽæ‚è‘g‚Ý

•ŸˆäŒ§“à‰Èˆã‰ïA¬–ì–ò•iH‹ÆŠ”Ž®‰ïŽÐ, ê–åE‹Æl

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

ŽÐ“àŒ¤C‰ï, PDAADŽ¾Š³Ž¡—Âɂ‚¢‚Ä

ƒmƒoƒ‹ƒeƒBƒXƒtƒ@[ƒ}Š”Ž®‰ïŽÐ, ê–åE‹Æl

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

¢ŠEƒAƒ‹ƒcƒnƒCƒ}[ƒf[‹L”OƒCƒxƒ“ƒgu’m‚Á‚ĂĈÀS!”F’mÇv, ”F’mÇ‚Æ“œ”A•a

•ŸˆäŒ§AŒö‰vŽÐ’c–@l”F’mÇ‚Ìl‚ƉƑ°‚Ì‰ï •ŸˆäŒ§Žx•”, ˆê”Ê

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

•ŸˆäƒNƒŠƒjƒJƒ‹ƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒZƒ~ƒi[, ƒAƒŠƒZƒvƒg‚ÌV‚½‚È“WŠJ

ƒG[ƒUƒCŠ”Ž®‰ïŽÐ, ê–åE‹Æl

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

ƒwƒ‹ƒXƒAƒbƒvƒZƒ~ƒi[in•Ÿˆä, ’m‚Á‚Ä‚¨‚«‚½‚¢!”F’mÇ‚Ì—\–h–@‚ƑΈ–@

•Ÿˆä•ú‘—(ŽåÃ)EƒNƒXƒŠ‚̃AƒIƒL(‹¤Ã), ˆê”Ê

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

Šwpu‰‰‰ï, ƒAƒŠƒZƒvƒg‚ÌV‚½‚È“WŠJ

ƒG[ƒUƒCŠ”Ž®‰ïŽÐ, ê–åE‹Æl

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

âˆä’n‹æ ”F’mǃZƒ~ƒi[, ”F’mÇŽ¡—Öò‚ÌŽg‚¢•û‚ɂ‚¢‚Ä

âˆä’n‹æˆãŽt‰ï,‘æˆêŽO‹¤Š”Ž®‰ïŽÐ, ê–åE‹Æl

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

‘æ2‰ñN-Pƒlƒbƒgƒ[ƒNŒ¤‹†‰ï, ”F’mÇf—Âɂ¨‚¯‚éÅV‚̘b‘è‚ɂ‚¢‚Ä

N-Pƒlƒbƒgƒ[ƒNŒ¤‹†‰ï/‘æˆêŽO‹¤Š”Ž®‰ïŽÐ, ê–åE‹Æl

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

‚©‚©‚è‚‚¯ˆãŽÀ‘HŒ¤Cƒfƒ‚Œ¤C, MMSE‚ðŽÀÛ‚És‚¢Œ‹‰Ê‚ð•ªÍ

—ä–k”F’mÇŽ¾Š³ˆã—ÃZƒ“ƒ^[, ê–åE‹Æl

ûM–ì@’‰‘¥

u‰‰EƒZƒ~ƒi[“™

‘æ4‰ñ•ŸˆäŠÌ‘Ÿ‰h—{ƒtƒH[ƒ‰ƒ€, ŠÌ«”]LJ•¹ŠÌd•ÏŠ³ŽÒ‚ɑ΂·‚éƒJƒ‹ƒjƒ`ƒ“‚Ì—L—p«‚ÌŒŸ“¢

‘å’Ë»–òŠ”Ž®‰ïŽÐ, ê–åE‹Æl

ª–{@•üK

u‰‰EƒZƒ~ƒi[“™

‘æ24‰ñ@‹ž“s”]_ŒoE–¬ŠÇ’´‰¹”gƒZƒ~ƒi[, À’·

ƒTƒmƒtƒBŠ”Ž®‰ïŽÐ, ê–åE‹Æl

ŽR‘º@C

u‰‰EƒZƒ~ƒi[“™

Ý‘îf—ÂƗհƒXƒRƒA, Ý‘îf—ÂƗհƒXƒRƒA

•ŸˆäŒ§ŠÅŒì‹¦‰ï, ê–åE‹Æl, 40l

*‘O“c@^O, ŽR‘º@C

u‰‰EƒZƒ~ƒi[“™

•½¬26”N“x@‚悤‚±‚»æ”y, ‚Z¶‚ÌE‹ÆŠÏˆç¬‚ð–Ú“I‚Æ‚µ‚½u‰‰

•ŸˆäŒ§—§“¡“‡‚“™ŠwZ, ‚Z¶

ŽR‘º@C

u‰‰EƒZƒ~ƒi[“™

“ú–{_ŒoŠw‰ï‘æ11‰ñ¶ŠU‹³ˆçƒZƒ~ƒi[, ŽÀKuŽt@“ú–{_ŒoŠw‰ï‘æ11‰ñ¶ŠU‹³ˆçƒZƒ~ƒi[@Hands|on6@’´‰¹”gièò“®–¬ƒGƒR[j

“ú–{_ŒoŠw‰ï, ê–åE‹Æl

ŽR‘º@C

u‰‰EƒZƒ~ƒi[“™

–k—¤’nˆæICT@ƒCƒmƒx[ƒVƒ‡ƒ“ƒZƒ~ƒi[, SCOPEŒ¤‹†ŠJ”­¬‰Ê”­•\@Ý‘îˆã—ÂƉîŒì‚ׂ̈̃Aƒ‰[ƒ€ƒAƒhƒoƒCƒU[Žx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†ŠJ”­

‘–±È–k—¤‘‡’ÊM‹Ç, ˆê”Ê

ŽR‘º@C

u‰‰EƒZƒ~ƒi[“™

‚Ó‚ê‚ ‚¢‚í‚©‚ΉïŠwK‰ï, ‚‚Ȃ²‚¤I”]‘²’†‚Ì—Ö

JA•ŸˆäŽs‚Ó‚ê‚ ‚¢‚í‚©‚Ήï, ˆê”Ê

ŽR‘º@C

u‰‰EƒZƒ~ƒi[“™

Fukui Stroke Network Meeting, u‰‰@SŒ´«”]Çð‚Ìŋ߂̘b‘è

“ú–{ƒx[ƒŠƒ“ƒK[ƒCƒ“ƒQƒ‹ƒnƒCƒ€Š”Ž®‰ïŽÐ, ê–åE‹Æl

ŽR‘º@C

u‰‰EƒZƒ~ƒi[“™

‘æ19‰ñŽ–—ጤ‹†•”‰ï@ƒwƒ‹ƒXƒPƒAƒCƒmƒx[ƒVƒ‡ƒ“ƒtƒH[ƒ‰ƒ€iHCIF), Ž–—á”­•\@SCOPEŽÀØŽ–‹Æ‚ɂ‚¢‚Ä@|Ý‘îˆã—ÂƉîŒì‚ׂ̈̃Aƒ‰[ƒ€ƒAƒhƒoƒCƒU[Žx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†ŠJ”­[

ƒwƒ‹ƒXƒPƒAƒCƒmƒx[ƒVƒ‡ƒ“ƒtƒH[ƒ‰ƒ€@iHCIFj, ê–åE‹ÆlEˆê”Ê

ŽR‘º@C

u‰‰EƒZƒ~ƒi[“™

•½¬26”N“x@•ŸˆäŒ§‰îŒìŽx‰‡ê–åˆõê–匤CEXVŒ¤CiŒoŒ±ŽÒj‰Û’ö‡T, ‚—îŽÒ‚ÌŽ¾•a‚ƑΈ‚¨‚æ‚ю厡ˆã‚Ƃ̘AŒg

ŽÐ‰ï•ŸŽƒ–@l@•ŸˆäŒ§ŽÐ‰ï•ŸŽƒ‹¦‹c‰ï, ê–åE‹Æl

ŽR‘º@C